StudyFinder
Search Results Within Category "Heart Health"
Here are the studies that match your search criteria. If you are interested in participating, please reach out to the contact listed for the study. If no contact is listed, contact us and we'll help you find the right person.
Search all categories
16 Study Matches
Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention (PROSe-ICD)
Katherine Wu, MD - kwu@jhmi.edu
NCT00733590
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
* History of acute MI at least 4 weeks old
* Non-ischemic LV dysfunction for at least 9 months
* Who have an ejection fraction (EF) \< or = to 35%
* Undergone elective replacement indicator (ERI) generator replacement of an FDA-approved ICD for primary prevention of SCD within 24 months of enrollment.
* Who have primary prevention implants.
Exclusion Criteria:
* ICD generator replacement for secondary prevention
* Inability or unwillingness to provide valid informed consent
* New York Heart Association Class IV heart failure
* Patients with pre-existing Class 1 indications for pacemaker therapy. Heart Failure, Congestive, Death, Sudden, Cardiac, Arrhythmia, Cardiomyopathies
defibrillator, implanted, genomics, electrocardiography, electrophysiological study, proteomics
I'm interested
Share via email
See this study on ClinicalTrials.gov
Show 4 locations
Study Locations
Hide all locations
| Location | Contacts |
|---|---|
| Johns Hopkins University School Of Medicine Baltimore, Maryland | Katherine Wu, MD - (kwu@jhmi.edu) |
| University of Maryland Medical Center Baltimore, Maryland | Stephen R Shorofsky, MD, PhD - (Sshorofs@medicine.umaryland.edu) |
| Virginia Commonwealth University School of Medicine Richmond, Virginia | Kenneth Ellenbogen, MD - (kellenbogen@pol.net) |
| Washington Hospital Center Washington D.C., District of Columbia | Zayd Eldadah, MD, PhD - (Zayd.Eldadah@Medstar.Net) |
Treating Heart Dysfunction Related to Cancer Therapy With Sacubitril/Valsartan (TREAT-HF)
Massey CTO CPC Team - masseycpc@vcu.edu
Bottinor, Wendy
NCT05194111
HM20023601
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
* Age \/=40% on echocardiogram or cardiac magnetic resonance imaging (MRI)
* No symptoms of heart failure (shortness of breath, fatigue, swelling). Ordinary physical activity does not cause undue fatigue, palpitation, dyspnea (shortness of breath).
Exclusion Criteria:
* -Age \<18 years
* Inability to obtain consent from patient or legally authorized representative
* Active acute or chronic psychiatric illness that in the opinion of the investigator may prevent compliance with study instructions
* Limited English or Spanish proficiency that in the opinion of the investigator may prevent understanding the content of the informed consent form or safely completing the study procedures
* Participation in another concurrent intervention study within 30 days or treatment with an investigational drug within 5 half-lives prior to randomization
* Greater than mild mitral or aortic valve regurgitation/stenosis known pre-cancer therapy
* Severe kidney disease (glomerular filtration rate (GFR) \<30 milliliters (mL)/minute (min)/1.73 meters squared (m2))
* Chronic hyperkalemia (\>5millimoles per liter (mmol/L))
* Evidence of Coronavirus (COVID-19) within the last 60 days or recent (21 days) exposure to close personal contact with COVID-19.
* Greater than moderate tricuspid or pulmonary valve regurgitation/stenosis known pre-cancer therapy
* Hemodynamically significant congenital heart disease in the opinion of the investigator (not including patent foramen ovale (PFO)/small atrial septal defect (ASD) or small ventricular septal defect (VSD))
* Greater than moderate pericardial effusion
* Constrictive cardiomyopathy diagnosed pre-cancer therapy
* Family history of genetic cardiomyopathy
* Evidence of infiltrative cardiomyopathy
* Symptomatic heart disease based on New York Heart Association (NYHA) classification
* Allergy to valsartan or sacubitril
* Inability to complete cardiac magnetic resonance (CMR) or 6-minute walk test
* Inability to measure non-invasive blood pressure and heart rate in the ambulatory/home setting
* Pregnant/lactating
* History of severe hypersensitivity reactions to gadolinium-based contrast agents (will perform limited cardiac imaging without contrast)
* Concomitant use of other angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBs), aliskiren, non-steroidal anti-inflammatories (NSAIDs) or lithium or the inability to stop these medications for the study DRUG: Sacubitril-valsartan, DRUG: Valsartan, DRUG: Carvedilol
Heart Failure, Heart Dysfunction
I'm interested
Share via email
See this study on ClinicalTrials.gov
Show 1 location
Study Locations
Hide all locations
| Location | Contacts |
|---|---|
| Virginia Commonwealth University Richmond, Virginia | Massey CTO CPC Team - (masseycpc@vcu.edu) |
Quality of Pediatric Resuscitation in a Multicenter Collaborative (pediRES-Q)
Vinay Nadkarni, MD, MS - nadkarni@chop.edu
NCT02708134
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
* Patient received chest compressions for at least 1 minute
* Patient between gestational age ≥37 weeks and 18 years of age
Exclusion Criteria:
* Patient on veno-arterial extracorporeal membrane oxygenation (ECMO) therapy at beginning of CPR event Cardiac Arrest, Cardiopulmonary Arrest
Chest compressions, Cardiopulmonary Resuscitation, Pediatric
I'm interested
Share via email
See this study on ClinicalTrials.gov
Show 61 locations
Study Locations
Hide all locations
| Location | Contacts |
|---|---|
| Aichi Children's Health and Medical Center Ōbu, | |
| Akron Children's Akron, Ohio | |
| Albany Medical Center Albany, New York | |
| Alberta Children's Calgary, | |
| All Children's Hospital St. Petersburg, Florida | |
| BC Children's Vancouver, British Columbia | |
| Boston Children's Boston, Massachusetts | |
| Cedars-Sinai Medical Center Los Angeles, California | |
| Children's Colorado Aurora, Colorado | |
| Children's Healthcare of Atlanta (CHOA) Atlanta, Georgia | |
| Children's Hospital of Philadelphia Philadelphia, Pennsylvania | Vinay Nadkarni, MD, MS - (nadkarni@chop.edu) |
| Children's Hospital of Richmond at VCU Richmond, Virginia | |
| Chldren's Hospital of Orange County Orange, California | |
| Cincinnati Children's Hospital Medical Center Cincinnati, Ohio | |
| Cohen Children's Medical Center New Hyde Park, New York | |
| Dartmouth Hitchcock Medical Center Lebanon, New Hampshire | |
| Dell Children's Medical Center Austin, Texas | |
| Erasmus MC - Sophia Children's Rotterdam, | |
| Great Ormond Street Hospital London, | |
| Gregorio Marañón General University Hospital Madrid, | |
| IRCCS Ospedale Pediatrico Bambino Gesu Rome, | |
| Instituto Roosevelt Bogotá, | |
| KK Women's & Children's Hospital Singapore, | |
| Kaiser Permanente San Francisco, California | |
| Kentucky Children's Hospital Lexington, Kentucky | |
| King Chulalongkorn University Bangkok, | |
| Kobe Children's Hospital (Hyogo Prefectural) Kobe, | |
| Lurie Children's (Children's Hospital of Chicago) Chicago, Illinois | |
| Massachusetts General Hospital Lexington, Massachusetts | |
| Medical City Children's Hospital Dallas, Texas | |
| Medical College of Wisconsin Milwaukee, Wisconsin | |
| Medical University of South Carolina Charleston, South Carolina | |
| Morgan Stanley Children's Hospital New York, New York | |
| Mount Sinai Kravis Children's Hospital New York, New York | |
| National Taiwan University Hospital Taipei, | |
| National University Hospital Singapore, | |
| Nationwide Children's Hospital Columbus, Ohio | |
| Nebraska Medical Center Omaha, Nebraska | |
| Nemours Children's Hospital Orlando, Florida | |
| Perth Children's Hospital Perth, Western Australia | |
| Queensland Children's Hospital South Brisbane, Queensland | |
| Rady Children's Hospital San Diego, California | |
| Riley Hospital for Children Indianapolis, Indiana | |
| Sabara Hospital Infantil São Paulo, | |
| Seattle Children's Hospital Seattle, Washington | |
| Seoul National University Bundang Hospital Seongnam, | |
| St. Louis Children's Hospital St Louis, Missouri | |
| Stanford University Stanford, California | |
| Starship Children's Hospital Grafton, Auckland | |
| Stollery Children's Hospital Edmonton, Alberta | |
| Stony Brook University Hospital Stony Brook, New York | |
| The Children's Hospital at Westmead Westmead, New South Wales | |
| The Children's Hospital of San Antonio San Antonio, Texas | |
| The Johns Hopkins Hospital Baltimore, Maryland | |
| Tokyo Metropolitan Children's Medical Center Tokyo, | |
| University of Chicago, Comer Children's Hospital Chicago, Illinois | |
| University of Iowa Stead Family Children's Hospital Iowa City, Iowa | |
| University of North Carolina Chapel Hill, North Carolina | |
| University of Texas Southwestern Dallas, Texas | |
| Upstate Golisano Children's Hospital Syracuse, New York | |
| Valley Children's Hospital Madera, California |
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery (ASPIRE)
Kevin N Sheth, MD - kevin.sheth@yale.edu
NCT03907046
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
* Age at least 18 years
* Intracerebral hemorrhage (ICH) (including primary intraventricular hemorrhage) confirmed by brain CT or MRI
* Can be randomized within 14-180 days after ICH onset
* Non-valvular AF (defined as atrial fibrillation or atrial flutter), documented by electrocardiography or a physician-confirmed history of prior AF
* Provision of signed and dated informed consent form by patient or legally authorized representative
* For females of reproductive potential: use of highly effective contraception
Exclusion Criteria:
* Index event is hemorrhagic transformation of a brain infarction or hemorrhage into a tumor
* History of earlier ICH within 12 months preceding index event
* Active infective endocarditis
* Clear indication for anticoagulant drugs (e.g., requires anticoagulation for deep vein thrombosis or pulmonary embolism) or antiplatelet drugs (e.g., requires aspirin or clopidogrel for recent coronary stent).
* Previous or planned left atrial appendage closure
* Clinically significant bleeding diathesis
* Serum creatinine ≥2.5 mg/dL
* Active hepatitis or hepatic insufficiency with Child-Pugh score B or C
* Anemia (hemoglobin \<8 g/dL) or thrombocytopenia (\<100 x 10\^9/L) that is chronic in the judgment of the investigator
* Pregnant or breastfeeding
* Known allergy to aspirin or apixaban
* Concomitant participation in a competing trial
* Considered by the investigator to have a condition that precludes safe or active participation in the trial
* Persistent, uncontrolled systolic blood pressure (≥180 mm Hg)
* ICH caused by an arteriovenous malformation (AVM) that has not yet been secured DRUG: Apixaban, DRUG: Aspirin
Intracerebral Hemorrhage, Atrial Fibrillation
I'm interested
Share via email
See this study on ClinicalTrials.gov
Show 187 locations
Study Locations
Hide all locations
| Location | Contacts |
|---|---|
| Abbott Northwestern Hospital Minneapolis, Minnesota | |
| Albany Medical Center Albany, New York | |
| Arrowhead Regional Medical Center Colton, California | |
| Ascension Sacred Heart Pensacola Pensacola, Florida | |
| Ascension St. John Medical Center Tulsa, Oklahoma | |
| Augusta University Medical Center Augusta, Georgia | |
| Avera Research Institute Sioux Falls, South Dakota | |
| Banner University Medical Center Phoenix, Arizona | |
| Baptist Health Lexington Lexington, Kentucky | |
| Barnes Jewish Hospital St Louis, Missouri | |
| Baylor College of Medicine Medical Center Houston, Texas | |
| Baystate Medical Center Springfield, Massachusetts | |
| Beth Israel Deaconess Medical Center Boston, Massachusetts | |
| Bon Secours St. Mary's Hospital Richmond, Virginia | |
| Boston Medical Center Boston, Massachusetts | |
| Broward Health Medical Center Fort Lauderdale, Florida | |
| Buffalo General Medical Center Buffalo, New York | |
| Burke Rehabilitation Center White Plains, New York | |
| Capital Health Regional Medical Center Pennington, New Jersey | |
| Carolinas Medical Center Charlotte, North Carolina | |
| Cedars-Sinai Medical Center Los Angeles, California | |
| Central DuPage Hospital Winfield, Illinois | |
| Chandler Regional Medical Center Chandler, Arizona | |
| Cleveland Clinic Cleveland, Ohio | |
| Cleveland Clinic Akron General Akron, Ohio | |
| Cleveland Clinic Tradition Hospital Port Saint Lucie, Florida | |
| Community Regional Medical Center of Fresno Fresno, California | |
| Cooperman Barnabas Medical Center Livingston, New Jersey | |
| Cox Medical Center South Springfield, Missouri | |
| Danbury Hospital Danbury, Connecticut | |
| Desert Regional Medical Center Palm Springs, California | |
| Doctors Medical Center Modesto, Modesto, CA Modesto, California | |
| Duke University Hospital Durham, North Carolina | |
| ECU Health Medical Center Greenville, North Carolina | |
| Eastern Maine Medical Center Bangor, Maine | |
| Eden Medical Center, Castro Valley Castro Valley, California | |
| Emory University Hospital Atlanta, Georgia | |
| Erlanger Health System Chattanooga, Tennessee | |
| Evanston Hospital Evanston, Illinois | |
| Forsyth Medical Center Winston-Salem, North Carolina | |
| Fort Sanders Regional Medical Center Knoxville, Tennessee | |
| Froedtert Hospital Milwaukee, Wisconsin | |
| Geisinger Medical Center Danville, Pennsylvania | |
| George Washington University Hospital Washington D.C., District of Columbia | |
| Good Samaritan Hospital Corvallis, Oregon | |
| Grady Memorial Hospital Delaware, Ohio | |
| Greenville Hospital System Greenville, South Carolina | |
| Hackensack University Medical Center Hackensack, New Jersey | |
| Harborview Medical Center Seattle, Washington | |
| Hartford Hospital Hartford, Connecticut | |
| HealthPartners Methodist Hospital Saint Louis Park, Minnesota | |
| Henry Ford Hospital Detroit, Michigan | |
| Hoag Hospital Newport Beach Newport Beach, California | |
| Hospital of the University of Pennsylvania Philadelphia, Pennsylvania | |
| Houston Methodist Hospital Houston, Texas | |
| Huntington Memorial Hospital Pasadena, California | |
| IU Health Methodist Hospital Indianapolis, Indiana | |
| Inova Fairfax Hospital Falls Church, Virginia | |
| J.W. Ruby Memorial Hospital Morgantown, West Virginia | |
| JFK Medical Center Edison, New Jersey | |
| Jackson Memorial Hospital Miami, Florida | |
| Javon Bea Hospital - Riverside Rockford, Illinois | |
| Jefferson Abington Hospital Abington, Pennsylvania | |
| Jersey Shore University Medical Center Neptune City, New Jersey | |
| Kaiser Permanente Fontana Medical Center Fontana, California | |
| Kaiser Permanente Los Angeles Medical Center Los Angeles, California | |
| Kaiser Permanente Redwood City Medical Center, Redwood City, CA Redwood City, California | |
| Kaiser Permanente Sacramento Medical Center Sacramento, California | |
| Kings County Hospital Center Brooklyn, New York | |
| Lahey Hospital & Medical Center Burlington, Massachusetts | |
| Lehigh Valley Hospital - Cedar Crest Allentown, Pennsylvania | |
| Long Beach Memorial Medical Center Long Beach, California | |
| Los Alamitos Medical Center Los Alamitos, California | |
| Loyola University Medical Center Maywood, Illinois | |
| M Health Fairview University of Minnesota Medical Center Minneapolis, Minnesota | |
| Maimonides Medical Center Brooklyn, New York | |
| Maine Medical Center Scarborough, Maine | |
| Massachusetts General Hospital Lexington, Massachusetts | |
| Mayo Clinic Rochester, Minnesota | |
| McLaren Flint Flint, Michigan | |
| McLaren Macomb Mount Clemens, Michigan | |
| MedStar Georgetown University Hospital Washington D.C., District of Columbia | |
| Medical University of South Carolina University Hospital Charleston, South Carolina | |
| Medstar Washington Hospital Center Washington D.C., District of Columbia | |
| Memorial Hermann Texas Medical Center Houston, Texas | |
| Mercy Hospital Oklahoma City Oklahoma City, Oklahoma | |
| Mercy Hospital South St Louis, Missouri | |
| Mercy Hospital Springfield Springfield, Missouri | |
| Mercy Hospital St. Louis St Louis, Missouri | |
| Mercy San Juan Medical Center Carmichael, California | |
| Methodist University Hospital Memphis, Tennessee | |
| Metro Health Hospital Wyoming, Michigan | |
| MetroHealth Medical Center Cleveland, Ohio | |
| Montefiore Medical Center The Bronx, New York | |
| Morton Plant Hospital Clearwater, Florida | |
| Moses H. Cone Memorial Hospital Greensboro, North Carolina | |
| Mount Sinai West New York, New York | |
| Munson Medical Center Traverse City, Michigan | |
| NCH Hospital, Arlington Heights Arlington Heights, Illinois | |
| NYC Health + Hospitals/Elmhurst Elmhurst, New York | |
| NYP Columbia University Medical Center New York, New York | |
| NYP Weill Cornell Medical Center New York, New York | |
| NYU Langone Hospital - Brooklyn Brooklyn, New York | |
| New Hanover Regional Medical Center Wilmington, North Carolina | |
| New Hanover Regional Medical Center Wilmington, North Carolina | |
| NewYork-Presbyterian Brooklyn Methodist Hospital Brooklyn, New York | |
| North Shore University Hospital Manhasset, New York | |
| OSF St. Francis Medical Center Peoria, Illinois | |
| OSU Wexner Medical Center Columbus, Ohio | |
| OU Medical Center Oklahoma City, Oklahoma | |
| Ochsner Medical Center - Main Campus New Orleans, Louisiana | |
| Oregon Health & Science University Hospital Portland, Oregon | |
| Overlook Medical Center Summit, New Jersey | |
| PIH Health Hospital - Whittier Whittier, California | |
| PeaceHealth Sacred Heart Medical Center - RiverBend Springfield, Oregon | |
| Penn State Hershey Medical Center Hershey, Pennsylvania | |
| Presbyterian Medical Center Philadelphia, Pennsylvania | |
| Providence St. Vincent Medical Center Portland, Oregon | |
| Rancho Los Amigos National Rehabilitation Center Downey, California | |
| Regions Hospital Saint Paul, Minnesota | |
| Rhode Island Hospital Providence, Rhode Island | |
| Riverside Methodist Hospital Columbus, Ohio | |
| Ronald Reagan UCLA Medical Center Los Angeles, California | |
| Rush University Medical Center Chicago, Illinois | |
| SUNY Upstate Medical University Syracuse, New York | |
| Saint Alphonsus Regional Medical Center - Boise Boise, Idaho | |
| San Francisco General Hospital San Francisco, California | |
| Santa Barbara Cottage Hospital Santa Barbara, California | |
| Semmes Murphey Main Campus Memphis, Tennessee | |
| St. Cloud Hospital Saint Cloud, Minnesota | |
| St. David's Medical Center Austin, Texas | |
| St. John Medical Center Tulsa, Oklahoma | |
| St. John's Hospital Springfield, Illinois | |
| St. Joseph's Hospital Tampa, Florida | |
| St. Joseph's Hospital and Medical Center Phoenix, Arizona | |
| St. Jude Medical Center Fullerton, California | |
| St. Mary's Medical Center Grand Junction, Colorado | |
| Stanford University Medical Center Palo Alto, California | |
| Staten Island University Hospital - North Campus Staten Island, New York | |
| Stony Brook University Hospital Stony Brook, New York | |
| Strong Memorial Hospital Rochester, New York | |
| Swedish Medical Center - Cherry Hill Campus Seattle, Washington | |
| Tampa General Hospital Tampa, Florida | |
| Temple University Hospital Philadelphia, Pennsylvania | |
| The Mount Sinai Hospital New York, New York | |
| The Queen's Medical Center Honolulu, Hawaii | |
| The University of Vermont Medical Center Burlington, Vermont | |
| Thomas Jefferson University Hospital Philadelphia, Pennsylvania | |
| Trinity Health Saint Mary's Grand Rapids, Michigan | |
| Trinity Health Saint Mary's Grand Rapids, Michigan | |
| Tufts Medical Center Boston, Massachusetts | |
| UAMS Medical Center Little Rock, Arkansas | |
| UC Davis Medical Center Sacramento, California | |
| UC Irvine Medical Center Orange, California | |
| UF Health Jacksonville Jacksonville, Florida | |
| UH Cleveland Medical Center Cleveland, Ohio | |
| UMass Memorial Medical Center Worcester, Massachusetts | |
| UPMC Presbyterian Hospital Pittsburgh, Pennsylvania | |
| UT Southwestern Medical Center Dallas, Texas | |
| UVA Medical Center Charlottesville, Virginia | |
| United Hospital, St. Paul Saint Paul, Minnesota | |
| University of Alabama Hospital Birmingham, Alabama | |
| University of Chicago Medical Center Chicago, Illinois | |
| University of Cincinnati Medical Center Cincinnati, Ohio | |
| University of Colorado Hospital Aurora, Colorado | |
| University of Illinois Hospital Chicago, Illinois | |
| University of Iowa Medical Center Iowa City, Iowa | |
| University of Kansas Hospital Kansas City, Kansas | |
| University of Kentucky Hospital Lexington, Kentucky | |
| University of Louisville Hospital Louisville, Kentucky | |
| University of Michigan University Hospital Ann Arbor, Michigan | |
| University of Mississippi Medical Center Jackson, Mississippi | |
| University of Missouri Health Care Columbia, Missouri | |
| University of Nebraska Medical Center Omaha, Nebraska | |
| University of New Mexico Hospital Albuquerque, New Mexico | |
| University of North Carolina Medical Center Chapel Hill, North Carolina | |
| University of South Alabama University Hospital Mobile, Alabama | |
| University of Texas Health Science Center San Antonio San Antonio, Texas | |
| University of Utah Healthcare Salt Lake City, Utah | |
| VCU Medical Center Richmond, Virginia | |
| Vanderbilt University Hospital Nashville, Tennessee | |
| Vassar Brothers Medical Center Poughkeepsie, New York | |
| Virginia Mason Medical Center Seattle, Washington | |
| Wake Forest Baptist Medical Center Winston-Salem, North Carolina | |
| Wellstar Kennestone Hospital Marietta, Georgia | |
| Westchester Medical Center Valhalla, New York | |
| Yale New Haven Hospital New Haven, Connecticut |
EXercise Cardiac Magnetic Resonance Assessment of Left Atrial Mechanics Following Ablation (EXCLAMATORY)
Pamela Grizzard - pamela.grizzard@vcuhealth.org
NCT06212791
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
* Age ≥18 years
* Diagnosis of paroxysmal AF
* Left ventricular ejection fraction ≥50%
* Scheduled for catheter ablation
* Able to speak, hear, and read English
* Willing and able to provide informed consent
Exclusion Criteria:
* Persistent or permanent AF
* Prior ablation (catheter based or surgical) for AF
* Significant sinus node dysfunction
* Implanted pacemaker or defibrillator
* Contraindication to or inability to complete cardiovascular magnetic resonance study
* Contraindication to or inability to complete exercise testing
* Chronic kidney disease with estimated glomerular filtration rate \<30 mL/min/1.73m2
* Severe left ventricular hypertrophy
* Unrelated cardiomyopathy that is expected to limit exercise capacity, including but not limited to:
* Hypertrophic cardiomyopathy
* Cardiac amyloidosis
* Constrictive pericarditis
* Pulmonary arterial hypertension
* Prior cardiac surgery
* Active pregnancy BEHAVIORAL: Self- Report Evaluation-Duke Activity Status Index, BEHAVIORAL: Self- Report Evaluation Atrial Fibrillation Effect on Quality of Life Questionnaire, DIAGNOSTIC_TEST: Cardiopulmonary exercise test (CPET), DIAGNOSTIC_TEST: Transthoracic echocardiogram, DIAGNOSTIC_TEST: Ambulatory cardiac rhythm assessment, DIAGNOSTIC_TEST: Cardiovascular magnetic resonance (CMR)
Paroxysmal Atrial Fibrillation
Catheter ablation, Exercise capacity
I'm interested
Share via email
Show 1 location
Study Locations
Hide all locations
| Location | Contacts |
|---|---|
| Virginia Commonwealth University Richmond, Virginia | Pamela Grizzard - (pamela.grizzard@vcuhealth.org) Melissa Sears - (melissa.sears@vcuhealth.org) |
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure (DRAIN-HF)
Rubi Reyes-Fuentez - rubi@procyrion.com
NCT05677100
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria (Randomized Study):
* Currently admitted to the hospital with a primary diagnosis of decompensated heart failure, irrespective of ejection fraction (EF);
* Patients should be on maximally tolerated diuretic therapy and not diuresing sufficiently before being enrolled in DRAIN-HF. After being up-titrated on diuretics, patients should be followed for at least 24 hours on the higher of: i) furosemide 80 mg IV bid or equivalent or ii) IV furosemide or equivalent IV loop diuretic at a dose 2.5 x total daily home dose of furosemide equivalents in 2 divided doses, as tolerated, patient must have: Urine Output \<1,500mL in a 12-hour period OR a Net Fluid Loss ≤375mL in a 12-hour period.
* Persistent signs and/or symptoms of congestion as evidenced by at least 2+ pitting edema, elevated jugular venous pressure \>12 cm water or ascites after treatment with IV diuretics per inclusion criterion 2.;
* Age \>21 years and able to provide written informed consent;
* Negative pregnancy test if patient is of child-bearing potential.
Exclusion Criteria (Randomized Study):
* Treatment with high dose IV inotropes within the last 48 hours prior to enrollment. High dose is defined as \>5 µg/kg/min dopamine OR \>5 µg/kg/min dobutamine OR \>0.375 µg/kg/min milrinone;
* Active and ongoing hypotension with a systolic blood pressure \<90 mmHg lasting more than 30 minutes or a mean arterial pressure (MAP) \<60 mmHg lasting more than 30 minutes at enrollment;
* Treatment with vasopressors (defined as phenylephrine, norepinephrine, epinephrine or, vasopressin) within 48 hours prior to enrollment;
* An estimated PASP of \>80 mmHg as measured on echocardiogram or echocardiographic evidence of primarily right heart failure;
* Acute kidney failure defined as an increase in serum creatinine to ≥4.0mg/dL (≥353.6 µmol/L) at enrollment;
* Evidence of contrast induced nephropathy, nephritis or nephrotic syndrome;
* Prior kidney transplant, single kidney, partial nephrectomy OR use of dialysis, continuous renal replacement therapy (CRRT) or ultrafiltration in the last 90 days prior to enrollment;
* Confirmed decompensated cirrhosis (defined as Child Pugh class B or C) or concern for shock liver (AST \> 1000U/L or total Bilirubin \> 5.0mg/dl) at enrollment;
* Presence of an active, uncontrolled infection that would preclude safe placement or removal of the device;
* Prior heart transplant or likely heart transplantation before the 30- day follow-up visit;
* Current or previous support with a durable LVAD at any time or planned LVAD insertion before the 30-day follow-up visit;
* Use of an intra-aortic balloon pump (IABP), extracorporeal membrane oxygenation (ECMO), or percutaneous ventricular assist devices (e.g. Impella or TandemHeart) within the last 30 days;
* Confirmed diagnosis of AL amyloidosis;
* Acute myocardial infarction Type 1 within 30 days of enrollment, or planned coronary revascularization in the next 30 days;
* Stroke within 30 days of enrollment;
* Severe Bleeding Risk (any of the following):
• Previous intracranial bleed unless there is documentation in the medical record (from a physician that is not part of the study) that the patient can safely use anticoagulation for 7 days,
• GI bleeding within 6 months requiring hospitalization and/or transfusion,
• Recent major surgery within 30 days if the surgical wound is judged to be associated with an increased risk of bleeding,
• Procedure with arterial ilio-femoral access \> 6 FR within 30 days,
• Platelet count \<75,000 cells/mm3,
• Uncorrectable bleeding diathesis or coagulopathy (e.g. INR ≥2 not due to anticoagulation therapy) or hypercoaguable state including HIT;
• Inability to tolerate anticoagulation therapy for up to 7 days. * Contraindicated Anatomy :
• Descending aortic anatomy that would prevent safe placement of the device \[\<18 mm or \>31 mm aorta diameter at deployment location (measured between the superior aspect of the T10 vertebra and superior aspect of the L1 vertebra)\],
• Ilio-femoral diameter or peripheral vascular anatomy that would preclude safe placement of a 21F (outer diameter) introducer sheath,
• Femoral artery depth inconsistent with use of closure device,
• Abnormalities or severe vascular disease that would preclude safe access and device delivery (e.g. aneurysm with thrombus, marked tortuosity, significant narrowing or inadequate size of the abdominal aorta, iliac or femoral arteries, or severe calcification),
• Known connective tissue disorder (e.g. Marfan Syndrome) or other aortopathy at risk of vascular injury,
• Any endovascular stent graft in the descending aorta. Any endovascular stent graft in the femoro-iliac vessels that is not well endothelialized and would preclude safe introduction/removal of the Aortix pump as demonstrated by imaging. * Known hypersensitivity or contraindication to study or procedure medications (e.g. anticoagulation therapy) or device materials (e.g. history of severe reaction to nickel or nitinol); * Participation in any other clinical investigation that is likely to confound study results or affect the study; * Poor health such that the patient is unable to undergo the Aortix device placement/retrieval and/or unlikely to be able to survive to the 30-day visit; * Unable or unwilling to undergo screening (imaging, PA Catheter placement), device implant and retrieval procedures or return for 30-day visit. Inclusion Criteria (Advanced Heart Failure Registry): * Currently admitted to the hospital with a primary diagnosis of decompensated HF, irrespective of ejection fraction (EF). * Patient has already been evaluated and indicated to receive an LVAD or heart transplant and will receive the LVAD or be listed for heart transplantation in the next 30 days if their congestion status and renal function improves. * Patient must have been treated with ≥ 80 mg IV furosemide bid or equivalent and have evidence of increasing diuretic dosing requirements over the past 12 months, as tolerated. * Must have evidence of refractoriness to medical management as documented by persistent signs and/or symptoms of congestion as evidenced by at least 2+ pitting edema, elevated jugular venous pressure \>12 cm water, or ascites after treatment with IV diuretics for a minimum of 24 hours. * Serum creatinine ≥ 2.0 mg/dL AND eGFR ≤ 45 ml/min/1.73m2 at time of enrollment * Age ≥ 21 years and able to provide written informed consent. * Negative pregnancy test if patient is of childbearing potential. Exclusion Criteria (Advanced Heart Failure Registry): * Treatment with high dose IV inotropes within 48 hours prior to enrollment. High dose is defined as any one of the following: \>5 µg/kg/min dopamine OR \>5 µg/kg/min dobutamine OR \>0.375 µg/kg/min milrinone. * Active and ongoing hypotension with a systolic blood pressure \<80 mmHg lasting more than 30 minutes or a mean arterial pressure (MAP) \<55 mmHg lasting more than 30 minutes at enrollment. * Treatment with vasopressors (defined as phenylephrine, norepinephrine, epinephrine or, vasopressin) within 48 hours prior to enrollment. * An estimated PASP of \>80 mmHg as measured on echocardiogram or echocardiographic evidence of primarily right heart failure. * Acute kidney failure defined as an increase in serum creatinine to ≥ 4.0mg/dL at enrollment. * Evidence of contrast-induced nephropathy, nephritis, or nephrotic syndrome. * Prior kidney transplant, single kidney, partial nephrectomy OR use of dialysis, continuous renal replacement therapy (CRRT), or ultrafiltration in the last 90 days prior to enrollment. * Confirmed decompensated cirrhosis (defined as Child Pugh class B or C) or concern for shock liver (AST \> 1000U/L or total Bilirubin \> 5.0mg/dl) at enrollment. * Presence of an active, uncontrolled infection that would preclude safe placement or removal of the device. * Current or previous support with a durable LVAD. * INTERMACS Profile 1 at enrollment. * Currently on mechanical ventilatory support. * Use of an extracorporeal membrane oxygenation (ECMO) or percutaneous ventricular assist device (e.g., Impella or TandemHeart) within the last 30 days. * Confirmed diagnosis of AL amyloidosis. * Acute myocardial infarction Type 1 within 30 days of enrollment or planned coronary revascularization in the next 30 days. * Stroke within 30 days of enrollment. * Severe Bleeding Risk (any of the following): * Previous intracranial bleed unless there is documentation in the medical record (from a physician that is not part of the study) that the patient can safely use anticoagulation for 7 days. * GI bleeding within 6 months requiring hospitalization and/or transfusion. * Recent major surgery within 30 days if the surgical wound is judged to be associated with an increased risk of bleeding. * Procedure with arterial ilio-femoral access \> 6 Fr within 30 days. * Platelet count \<75,000 cells/mm3 . * Uncorrectable bleeding diathesis or coagulopathy (e.g., INR≥ 2 not due to anticoagulation therapy) or hypercoagulable state including HIT. * Inability to tolerate anticoagulation therapy for up to 7 days. * Contraindicated Anatomy : * Descending aortic anatomy that would prevent safe placement of the device \[\<18 mm or \>31 mm aorta diameter at deployment location (measured between the superior aspect of the T10 vertebra and superior aspect of the L1 vertebra)\]. * Ilio-femoral diameter or peripheral vascular anatomy that would preclude safe placement of a 21 Fr (outer diameter) introducer sheath. * Femoral artery depth inconsistent with use of closure device. * Abnormalities or severe vascular disease that would preclude safe access and device delivery (e.g., aneurysm with thrombus; marked tortuosity; significant narrowing or inadequate size of the abdominal aorta, iliac, or femoral arteries; or severe calcification). * Known connective tissue disorder (e.g., Marfan Syndrome) or other aortopathy at risk of vascular injury. * Any endovascular stent graft in the descending aorta. Any endovascular stent graft in the femoro-iliac vessels that is not well endothelialized and would preclude safe introduction/removal of the Aortix pump as demonstrated by imaging. * Known hypersensitivity or contraindication to study or procedure medications (e.g., anticoagulation therapy) or device materials (e.g., history of severe reaction to nickel or nitinol). * Participation in any other clinical investigation that is likely to confound study results or affect the study. * Poor health such that the patient is unable to undergo the Aortix device placement/retrieval and/or unlikely to be able to survive to the 30-day visit. * Unable or unwilling to undergo screening, device implant and retrieval procedures, or return for 30-day visit.
• Previous intracranial bleed unless there is documentation in the medical record (from a physician that is not part of the study) that the patient can safely use anticoagulation for 7 days,
• GI bleeding within 6 months requiring hospitalization and/or transfusion,
• Recent major surgery within 30 days if the surgical wound is judged to be associated with an increased risk of bleeding,
• Procedure with arterial ilio-femoral access \> 6 FR within 30 days,
• Platelet count \<75,000 cells/mm3,
• Uncorrectable bleeding diathesis or coagulopathy (e.g. INR ≥2 not due to anticoagulation therapy) or hypercoaguable state including HIT;
• Inability to tolerate anticoagulation therapy for up to 7 days. * Contraindicated Anatomy :
• Descending aortic anatomy that would prevent safe placement of the device \[\<18 mm or \>31 mm aorta diameter at deployment location (measured between the superior aspect of the T10 vertebra and superior aspect of the L1 vertebra)\],
• Ilio-femoral diameter or peripheral vascular anatomy that would preclude safe placement of a 21F (outer diameter) introducer sheath,
• Femoral artery depth inconsistent with use of closure device,
• Abnormalities or severe vascular disease that would preclude safe access and device delivery (e.g. aneurysm with thrombus, marked tortuosity, significant narrowing or inadequate size of the abdominal aorta, iliac or femoral arteries, or severe calcification),
• Known connective tissue disorder (e.g. Marfan Syndrome) or other aortopathy at risk of vascular injury,
• Any endovascular stent graft in the descending aorta. Any endovascular stent graft in the femoro-iliac vessels that is not well endothelialized and would preclude safe introduction/removal of the Aortix pump as demonstrated by imaging. * Known hypersensitivity or contraindication to study or procedure medications (e.g. anticoagulation therapy) or device materials (e.g. history of severe reaction to nickel or nitinol); * Participation in any other clinical investigation that is likely to confound study results or affect the study; * Poor health such that the patient is unable to undergo the Aortix device placement/retrieval and/or unlikely to be able to survive to the 30-day visit; * Unable or unwilling to undergo screening (imaging, PA Catheter placement), device implant and retrieval procedures or return for 30-day visit. Inclusion Criteria (Advanced Heart Failure Registry): * Currently admitted to the hospital with a primary diagnosis of decompensated HF, irrespective of ejection fraction (EF). * Patient has already been evaluated and indicated to receive an LVAD or heart transplant and will receive the LVAD or be listed for heart transplantation in the next 30 days if their congestion status and renal function improves. * Patient must have been treated with ≥ 80 mg IV furosemide bid or equivalent and have evidence of increasing diuretic dosing requirements over the past 12 months, as tolerated. * Must have evidence of refractoriness to medical management as documented by persistent signs and/or symptoms of congestion as evidenced by at least 2+ pitting edema, elevated jugular venous pressure \>12 cm water, or ascites after treatment with IV diuretics for a minimum of 24 hours. * Serum creatinine ≥ 2.0 mg/dL AND eGFR ≤ 45 ml/min/1.73m2 at time of enrollment * Age ≥ 21 years and able to provide written informed consent. * Negative pregnancy test if patient is of childbearing potential. Exclusion Criteria (Advanced Heart Failure Registry): * Treatment with high dose IV inotropes within 48 hours prior to enrollment. High dose is defined as any one of the following: \>5 µg/kg/min dopamine OR \>5 µg/kg/min dobutamine OR \>0.375 µg/kg/min milrinone. * Active and ongoing hypotension with a systolic blood pressure \<80 mmHg lasting more than 30 minutes or a mean arterial pressure (MAP) \<55 mmHg lasting more than 30 minutes at enrollment. * Treatment with vasopressors (defined as phenylephrine, norepinephrine, epinephrine or, vasopressin) within 48 hours prior to enrollment. * An estimated PASP of \>80 mmHg as measured on echocardiogram or echocardiographic evidence of primarily right heart failure. * Acute kidney failure defined as an increase in serum creatinine to ≥ 4.0mg/dL at enrollment. * Evidence of contrast-induced nephropathy, nephritis, or nephrotic syndrome. * Prior kidney transplant, single kidney, partial nephrectomy OR use of dialysis, continuous renal replacement therapy (CRRT), or ultrafiltration in the last 90 days prior to enrollment. * Confirmed decompensated cirrhosis (defined as Child Pugh class B or C) or concern for shock liver (AST \> 1000U/L or total Bilirubin \> 5.0mg/dl) at enrollment. * Presence of an active, uncontrolled infection that would preclude safe placement or removal of the device. * Current or previous support with a durable LVAD. * INTERMACS Profile 1 at enrollment. * Currently on mechanical ventilatory support. * Use of an extracorporeal membrane oxygenation (ECMO) or percutaneous ventricular assist device (e.g., Impella or TandemHeart) within the last 30 days. * Confirmed diagnosis of AL amyloidosis. * Acute myocardial infarction Type 1 within 30 days of enrollment or planned coronary revascularization in the next 30 days. * Stroke within 30 days of enrollment. * Severe Bleeding Risk (any of the following): * Previous intracranial bleed unless there is documentation in the medical record (from a physician that is not part of the study) that the patient can safely use anticoagulation for 7 days. * GI bleeding within 6 months requiring hospitalization and/or transfusion. * Recent major surgery within 30 days if the surgical wound is judged to be associated with an increased risk of bleeding. * Procedure with arterial ilio-femoral access \> 6 Fr within 30 days. * Platelet count \<75,000 cells/mm3 . * Uncorrectable bleeding diathesis or coagulopathy (e.g., INR≥ 2 not due to anticoagulation therapy) or hypercoagulable state including HIT. * Inability to tolerate anticoagulation therapy for up to 7 days. * Contraindicated Anatomy : * Descending aortic anatomy that would prevent safe placement of the device \[\<18 mm or \>31 mm aorta diameter at deployment location (measured between the superior aspect of the T10 vertebra and superior aspect of the L1 vertebra)\]. * Ilio-femoral diameter or peripheral vascular anatomy that would preclude safe placement of a 21 Fr (outer diameter) introducer sheath. * Femoral artery depth inconsistent with use of closure device. * Abnormalities or severe vascular disease that would preclude safe access and device delivery (e.g., aneurysm with thrombus; marked tortuosity; significant narrowing or inadequate size of the abdominal aorta, iliac, or femoral arteries; or severe calcification). * Known connective tissue disorder (e.g., Marfan Syndrome) or other aortopathy at risk of vascular injury. * Any endovascular stent graft in the descending aorta. Any endovascular stent graft in the femoro-iliac vessels that is not well endothelialized and would preclude safe introduction/removal of the Aortix pump as demonstrated by imaging. * Known hypersensitivity or contraindication to study or procedure medications (e.g., anticoagulation therapy) or device materials (e.g., history of severe reaction to nickel or nitinol). * Participation in any other clinical investigation that is likely to confound study results or affect the study. * Poor health such that the patient is unable to undergo the Aortix device placement/retrieval and/or unlikely to be able to survive to the 30-day visit. * Unable or unwilling to undergo screening, device implant and retrieval procedures, or return for 30-day visit.
DEVICE: Aortix System
Heart Failure, Cardiorenal Syndrome, Cardio-Renal Syndrome, ADHF, Heart Failure, Systolic, Heart Failure, Diastolic, Heart Failure, With Decompensation, Heart Failure, Congestive
mechanical circulatory support, percutaneous
I'm interested
Share via email
Show 50 locations
Study Locations
Hide all locations
| Location | Contacts |
|---|---|
| AdventHealth Tampa Tampa, Florida | |
| Advocate Aurora - Good Samaritan Downers Grove, Illinois | |
| Advocate IMMC Chicago, Illinois | |
| AnMed Health Anderson, South Carolina | |
| Ascenscion Alexian Brothers Elk Grove Village, Illinois | |
| Ascension Sacred Heart Pensacola, Florida | |
| Ascension via Christi Kansas Wichita, Kansas | |
| Atrium Health Sanger Heart and Vascular Institute Charlotte, North Carolina | |
| Banner--University Medical Center Phoenix Phoenix, Arizona | |
| BayCare Medical/St. Joseph's Hospital Tampa, Florida | |
| Baylor Scott & White Plano, Texas | |
| Baylor Scott & White Plano, Texas | |
| Broward Health Fort Lauderdale, Florida | |
| Cleveland Clinic Florida Stuart, Florida | |
| Duke University Medical Center Durham, North Carolina | |
| Emory University Hospital Atlanta, Georgia | |
| Hackensack University Medical Center Hackensack, New Jersey | |
| Henry Ford Detroit, Michigan | |
| HonorHealth Medical Center Scottsdale, Arizona | |
| Intermountain Health Salt Lake City, Utah | |
| Jefferson Abington Hospital Abington, Pennsylvania | |
| Jersey Shore University Medical Center Neptune City, New Jersey | |
| John Muir Health Walnut Creek, California | |
| Mayo Clinic - Arizona Scottsdale, Arizona | Erica Boyd - (boyd.erica@mayo.edu) |
| Mount Sinai Morningside Manhattan, New York | |
| New York Presbyterian - Brooklyn Methodist Hospital Brooklyn, New York | Jhane Phanor - (jhp4004@nyp.org) |
| Northwell Health (Lenox Hill) New York, New York | |
| Northwell Health (Staten Island) Staten Island, New York | |
| Novant Health New Hanover Regional Medical Center Wilmington, North Carolina | |
| Nuvance Health Poughkeepsie, New York | |
| Nyph/Cumc New York, New York | |
| Oklahoma Cardiovascular Research Group Oklahoma City, Oklahoma | |
| Oregon Health & Sciences University Portland, Oregon | |
| Penn Presbyterian Medical Center Philadelphia, Pennsylvania | |
| Piedmont Healthcare INC. Augusta, Georgia | |
| San Francisco Veterans Administration San Francisco, California | |
| Semmelweis University Budapest, | Laura Kosa-Hobor - (hobor.laura@semmelweis.hu) |
| Tallahassee Research Institute Tallahassee, Florida | |
| Texas Heart Institute Houston, Texas | |
| The Ohio State University Columbus, Ohio | |
| Thomas Jefferson University Hospital Philadelphia, Pennsylvania | |
| University of California San Francisco San Francisco, California | |
| University of Chicago Chicago, Illinois | |
| University of Michigan, Cardiovascular Medicine Ann Arbor, Michigan | |
| University of Mississippi Medical Center Jackson, Mississippi | |
| University of South Florida Tampa, Florida | |
| University of Virginia Charlottesville, Virginia | |
| Virginia Commonwealth University Richmond, Virginia | |
| Wellstar Research Institue Marietta, Georgia | |
| Zuckerberg San Francisco General San Francisco, California |
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation (REACT-AF)
Anna Baranova - anna.baranova2@vcuhealth.org
NCT05836987
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
• 22-85 years of age.
• English speaking participants. Spanish-only speakers may be included in the future at select sites appropriately translated.
• History of non-permanent atrial fibrillation.
• CHA2DS2-VASC score of 1-5 for men and 2-5 for women without prior stroke or Transient Ischemic Attack (TIA), The CHA2DS2-VASc score is a point-based system used to stratify the risk of stroke in Atrial Fibrillation (AF) patients. The acronym CHA2DS2-VASc stands for congestive heart failure, hypertension, age ≥75 (doubled), diabetes, stroke (doubled), vascular disease, age 65 to 74 and sex category (female). Congestive heart failure defined as: The presence of signs and symptoms of either right (elevated central venous pressure, hepatomegaly, dependent edema) or left ventricular failure (exertional dyspnea, cough, fatigue, orthopnea, paroxysmal nocturnal dyspnea, cardiac enlargement, rales, gallop rhythm, pulmonary venous congestion) or both, confirmed by non-invasive or invasive measurements demonstrating objective evidence of cardiac dysfunction and/or ejection fraction \< 40%.
• The participant is on a DOAC at the time of screening and willing to stay on DOAC for duration of study.
• Willing and able to comply with the protocol, including: * Possession of a smart watch-compatible smart phone (iPhone that supports the latest shipping iOS) with a cellular service plan * Be willing to wear the smart watch for the suggested minimum of 14 hours a day * Expected to be within cellular service range at least 80% of the time
• Willing and able to discontinue DOAC
• The participant is willing and able to provide informed consent.
Exclusion Criteria:
• Valvular or permanent atrial fibrillation.
• Current treatment with warfarin and unwilling or unable to take a DOAC.
• The participant is a woman who is pregnant or nursing.
• The participant is being treated with chronic daily oral NSAIDs and is unwilling or unable to discontinue use for the study duration. Use of low-dose aspirin is permitted.
• Existing cardiac rhythm device or indication for a permanent pacemaker, Implantable Cardioverter-Defibrillator (ICD) or Cardiac Resynchronization Therapy (CRT) device or planned insertable cardiac monitor. Insertable cardiac monitors are permitted unless they are being used to guide anticoagulation treatment.
• Known or suspected symptomatic or asymptomatic atrial fibrillation lasting ≥ 1 hour/month over the last 3 months.
• Any documented single AF episode lasting ≥ 1 hour on a cardiac monitor performed within 90 days prior to randomization.
• Ablation for AF within the last 2 months.
• Prior or anticipated left atrial appendage occlusion or ligation.
• Mechanical prosthetic valve(s) or severe valve disease.
• Hypertrophic cardiomyopathy.
• Participant needs DOAC for reasons other than preventing stroke or arterial embolism resulting from AF (i.e., preventing Deep Vein Thrombosis (DVT) or PE) or needs permanent OAC (i.e., congenital heart defects, prosthetic heart valve).
• Participants deemed high risk for non-cardioembolic stroke (i.e., significant carotid artery disease defined as stenosis \> 75%) based on the investigator's discretion.
• The participant is enrolled, has participated within the last 30 days, or is planning to participate in a concurrent drug and/or device study during the course of this clinical trial. Co-enrollment in concurrent trials is only allowed with documented pre-approval from the study manager; there is no concern that co-enrollment could confound the results of this trial.
• The participant has a tattoo, birthmark, or surgical scar over the dorsal wrist area on the ipsilateral side that the AFSW may be worn.
• The participant has a tremor on their ipsilateral side that the AFSW may be worn.
• Any concomitant condition that, in the investigator's opinion, would not allow safe participation in the study (e.g., drug addiction, alcohol abuse).
• Known hypersensitivity or contraindication to direct oral anticoagulants.
• Documented prior stroke (ischemic or hemorrhagic) or transient ischemic attack.
• Reversible causes of AF (e.g., cardiac surgery, pulmonary embolism, untreated hyperthyroidism). AF ablation does not constitute reversible AF.
• \> 5% burden of premature atrial or ventricular depolarizations on pre-enrollment cardiac monitoring.
• History of ECG-documented, sustained atrial flutter that has not been treated with ablation (participants with atrial flutter who have been ablated are eligible for enrollment)
• Stage 4 or 5 chronic kidney disease.
• Conditions associated with an increased risk of bleeding: * Major surgery in the previous month * Planned surgery or intervention in the next three months that would require cessation of anticoagulation \> 2 weeks. * History of intracranial, intraocular, spinal, retroperitoneal, or atraumatic intra- articular bleeding * Gastrointestinal hemorrhage within the past year unless the cause has been permanently eliminated (e.g., by surgery) * Symptomatic or endoscopically documented gastroduodenal ulcer disease in the previous 30 days * Hemorrhagic disorder or bleeding diathesis * Need for anticoagulant treatment for disorders other than AF * Uncontrolled hypertension (Systolic Blood Pressure \>180 mmHg and/or Diastolic Blood Pressure \>100 mmHg)
DEVICE: AFSW Guided DOAC, DRUG: Continuous DOAC therapy
Atrial Fibrillation
Atrial Fibrillation, Anticoagulation, AF-sensing Smart Watch, Ischemic Stroke, Systemic Embolism
I'm interested
Share via email
Show 93 locations
Study Locations
Hide all locations
| Location | Contacts |
|---|---|
| Advanced Heart and Vascular Institute of Hunterdon Flemington, New Jersey | Alexis Bellafiore - (abellafiore@ahvi-nj.com) Jessica Senatore - (jsenatore@ahvi-nj.com) |
| Alexian Brothers Health System Elk Grove Village, Illinois | Michelle Garcia - (michelle.garcia5@ascension.org) Jeanine Pilat - (jeanine.pilat@ascension.org) |
| Allegheny Singer Research Institute Pittsburgh, Pennsylvania | Caitlin Phalunas - (caitlin.phalunas@ahn.org) Elizabeth Belden - (elizabeth.belden@ahn.org) |
| Ascension St. Vincent Indianapolis, Indiana | Regina Margiotti - (regina.margiotti@ascension.org) Ann Renick - (anne.renick@ascension.org) |
| BMC - Brighton Boston, Massachusetts | Rina Vaquerano - (rina.vaquerano@steward.org) |
| Banner University Phoenix, Arizona | Herisse Sabulao - (herisse.sabulao@bannerhealth.com) Raeven Maxwell - (raeven.maxwell@bannerhealth.com) |
| BayCare Health Systems Clearwater, Florida | Karen Herring - (karen.herring@baycare.org) |
| Baycare Health Systems Clearwater Winter Haven, Florida | Amanda Steadham - (Amanda.Steadham@baycare.org) Lynda Argenzio - (lynda.argenzio@baycare.org) |
| Baylor College of Medicine Houston, Texas | Stephen Harold - (harold@bcm.edu) |
| Beth Israel Deaconess Medical Center Boston, Massachusetts | Jenifer M Kaufman - (jmkaufma@bidmc.harvard.edu) Patricia Tyler - (ptyler@bidmc.harvard.edu) |
| Boston Medical Center Boston, Massachusetts | Laura Gavrilles - (laura.gavrilles@bmc.org) |
| Brigham and Women's Hospital Boston, Massachusetts | Daniela Hincapie Tabres - (dhincapietabares@bwh.harvard.edu) Obadah Aloum - (OALOUM@BWH.HARVARD.EDU) |
| Cardiology Consultants of Philadelphia Paoli, Pennsylvania | Hope Bernhardy - (hopeb@ccpdocs.com) |
| Cleveland Clinic Florida Stuart, Florida | |
| Columbia University Medical Center New York, New York | Raghd Ahmed - (ria2120@cumc.columbia.edu) |
| Corewell Health (Former Spectrum Health) Grand Rapids, Michigan | Lisa Van Loo - (lisa.vanloo@spectrumhealth.org) Jose Gavina - (jose.gavina@corewellhealth.org) |
| Emory University Atlanta, Georgia | Thomas Preiser - (tpreise@emory.edu) |
| Essentia Health The Duluth Clinic Duluth, Minnesota | |
| Georgia Arrhythmia Consultants and Research Institute Warner Robins, Georgia | Gbenga Adeyinka - (Gadeyinka@gacri.com) Abbey McGlashan - (amcglashan@gacri.com) |
| Hackensack Meridian Health Hackensack, New Jersey | Jennifer Baxter - (jennifer.baxter@hmhn.org) |
| Hennepin Healthcare Research Institute Minneapolis, Minnesota | Sahil Thummar - (sthummar@bermancenter.org) |
| Henry Ford Health Detroit, Michigan | Briita Wanhala - (bwanhal1@hfhs.org) Danielle Delmotte - (ddelmot2@hfhs.org) |
| Houston Methodist Hospital Houston, Texas | Chinwe Ngumezi - (ccngumezi@houstonmethodist.org) |
| James River Cardiology Richmond, Virginia | Janet Barrett - (Janet.Barrett@alignedcardio.com) |
| Johns Hopkins Univeristy Baltimore, Maryland | Michele Martucci - (mmill148@jhmi.edu) Natalie Horstman - (nhorstm3@jhu.edu) |
| Kaiser Permanente San Francisco, California | Annie Lei - (Annie.X.Lei@kp.org) Quyen Chau - (Quyen.X.Chau@kp.org) |
| Lahey Hospital & Medical Center Burlington, Massachusetts | Jean Byrne - (jean.byrne@lahey.org) |
| Loyola University Chicago Chicago, Illinois | Nancy Schoenecker - (nschoenecker@luc.edu) Jean Del Priore - (jdelpri@luc.edu) |
| MUSC Health Heart and Vascular Columbia, South Carolina | Jacqueline Sheriod-Scott - (sheriods@musc.edu) |
| Maine Medical Partners MaineHealth Cardiology Scarborough, Maine | Hilary Curtis - (hilary.curtis@mainehealth.org) Brenda Galsgow - (brenda.glasgow@mainehealth.org) |
| Mass General Hospital Boston, Massachusetts | Kristen Steinmetz - (ksteinmetz@mgh.harvard.edu) |
| Mayo Clinic Rochester, Minnesota | Pamela Wong - (WongLucio.Pamela@mayo.edu) |
| Medical College of Wisconsin Froedtert Hospital Milwaukee, Wisconsin | Debbi Hoff - (dhoff@mcw.edu) |
| Medical Faculty Associates George Washington University Washington D.C., District of Columbia | |
| Medical University of South Carolina Charleston, South Carolina | Krista Szymanski - (szymankr@musc.edu) |
| Midwest Cardiovascular Institute Naperville, Illinois | Josilyn Klimek - (Josilyn.Klimek@cardio.com) |
| Minneapolis Heart Institute Foundation Minneapolis, Minnesota | Andrew Garner - (andrew.garner@allina.com) Julianne Feola - (julianne.feola@allina.com) |
| NYU Langone Health New York, New York | Mollie Machado - (mollie.machado@nyulangone.org) |
| NewYork Presbyterian - Queens Queens, New York | Jackson Ng - (jan9044@nyp.org) |
| NorthShore University Healthsystem Evanston, Illinois | Marisa Durante - (mdurante@northshore.org) |
| Northwestern University Chicago, Illinois | CTU Regulatory Team - (cturegulatoryteam@nm.org) |
| Ohio State University Medical Center Columbus, Ohio | Adrianne Miller - (adrianne.miller3@osumc.edu) Ashley Thomas - (ashley.thomas@osumc.edu) |
| OhioHealth Research Institute Columbus, Ohio | Reem Bekheet - (reem.bekheet@ohiohealth.com) |
| Penn State Health Medical Group Berks Cardiology Wyomissing, Pennsylvania | Emese Futchko - (efutchko@pennstatehealth.psu.edu) Michelle Feltenberger - (mfeltenberger@pennstatehealth.psu.edu) |
| Presbyterian Healthcare Services Albuquerque, New Mexico | |
| Rhode Island Hospital Providence, Rhode Island | Kelly Franchetti - (kfranchetti@brownhealth.org) |
| Rush University Medical Center Chicago, Illinois | Nusrat Jahan - (nusrat_jahan@rush.edu) Christine Radochonski - (Christine_Radochonski@rush.edu) |
| Rutgers, the State University of New Jersey Piscataway, New Jersey | Glaucia Dos Santos-Vaccaro - (gd301@rwjms.rutgers.edu) |
| Sarasota Memorial Health Care System Sarasota, Florida | |
| Scripps Health San Diego, California | Janet Lawrence - (Lawrence.Janet@scrippshealth.org) |
| South Denver Cardiology Associates, P.C. Littleton, Colorado | Kathrin Siegel - (ksiegel@southdenver.com) |
| St. Elizabeth's Medical Center Washington D.C., District of Columbia | Rina Vaquerano - (rina.vaquerano@steward.org) |
| St. Joseph Medical Center Tacoma Tacoma, Washington | Boyoung Moore - (boyoung.moore@commonspirit.org) |
| Stanford University Stanford, California | Diona Gjermeni, MD - (gjermeni@stanford.edu) |
| Staten Island University Hospital-Northwell Health Staten Island, New York | Alexandra Pantea - (apantea@northwell.edu) |
| Stony Brook University Stony Brook, New York | Melanie Rooney - (melanie.rooney@stonybrookmedicine.edu) Michelle Xikis - (Michele.xikis@stonybrookmedicine.edu) |
| Texas Cardiac Arrhythmia Research Foundation Austin, Texas | Deb Cardinal - (dscardinal@austinheartbeat.com) |
| The Lindner Center for Research and Education at The Christ Hospital Cincinnati, Ohio | Anne Voorhorst - (anne.voorhorst@thechristhospital.com) |
| The Valley Hospital, Inc. Ridgewood, New Jersey | RoseMarie Hroncich - (rhronci@valleyhealth.com) |
| Thomas Jefferson University Philadelphia, Pennsylvania | Ashley Borgella - (ashley.borgella@jefferson.edu) |
| Trinity Health Grand Rapids/Mercy Health Grand Rapids, Michigan | Melissa Brown-Culbertson - (melissa.brown-culbertson@trinity-health.org) Nicolina Evola - (Nicolina.evola@trinity-health.org) |
| Trinity Health Michigan Heart - Ann Arbor Ypsilanti, Michigan | Autumn Howe - (ahowe@michiganheart.com) |
| Tufts Medical Center Boston, Massachusetts | Juan Carlos Collado Falcon - (Juan.Carlos.Collado.Falcon@tuftsmedicine.org) Abena Adwetewa-Badu - (Abena.Adwetewa-Badu@tuftsmedicine.org) |
| UC Davis Health Sacramento, California | Edward Lingayo - (lingayo@health.ucdavis.edu) |
| UMass Chan Medical School Worcester, Massachusetts | |
| University Health Truman Medical Center Kansas City, Missouri | |
| University at Buffalo Buffalo, New York | Courtney Bishop - (cabishop@buffalo.edu) Cassandra Davern - (cadavern@buffalo.edu) |
| University of California Los Angeles (UCLA Health) Los Angeles, California | Monserrath Campos - (monserrathcampos@mednet.ucla.edu) |
| University of Chicago Chicago, Illinois | Shahram Sarrafi - (ssarrafi1@uchicagomedicine.org) Kie Ng - (kie@bsd.uchicago.edu) |
| University of Cincinnati College of Medicine Cincinnati, Ohio | Elias Shamieh - (shamiees@ucmail.uc.edu) |
| University of Colorado Aurora, Colorado | Megan Collett - (megan.collett@uchealth.org) |
| University of Florida Gainesville, Florida | Walter Erikson - (erikson.walter@medicine.ufl.edu) Vanessa Scheuble - (vanessa.scheuble@medicine.ufl.edu) |
| University of Illinois Chicago Chicago, Illinois | David Sanders, MD - (djsand13@uic.edu) |
| University of Iowa Hospitals and Clinics Iowa City, Iowa | Trisha Elliott - (trisha-elliott@uiowa.edu) |
| University of Miami - Leonard S. Miller SOM Miami, Florida | Carmen Maria Baez-Garcia - (cbaezgarcia@med.miami.edu) |
| University of Minnesota Minneapolis, Minnesota | Julie Dicken - (dicke022@umn.edu) Maddy Chopp - (Chopp015@umn.edu) |
| University of New Mexico Health Sciences Center Albuquerque, New Mexico | Elvia Padilla - (EPadillaMendez@salud.unm.edu) Noela Garcia-Soberanez - (NGarciaSoberanez@salud.unm.edu) |
| University of North Carolina Chapel Hill, North Carolina | Elias Wen - (elias_wen@med.unc.edu) |
| University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma | Stephan Biheng - (Stephan-Biheng@ou.edu) |
| University of Southern California - Keck School of Medicine Los Angeles, California | Rohit Varma - (RohitVarma.Penmetsa@med.usc.edu) Stephanie Chao - (Stephanie.Chao@med.usc.edu) |
| University of Texas Health Science Center at Houston Houston, Texas | Mary Pierce - (mary.h.pierce@uth.tmc.edu) Vickie Ramirez - (vickie.m.ramirez@uth.tmc.edu) |
| University of Texas Southwestern Medical Center Dallas, Texas | Vukile Mlambo - (vukile.mlambo@utsouthwestern.edu) |
| University of Utah Salt Lake City, Utah | Andy Rivera - (andy.rivera@hsc.utah.edu) |
| University of Virginia Charlottesville, Virginia | Cathy Roy - (cjp6t@virginia.edu) |
| University of Wisconsin Madison, Wisconsin | Karen Olson - (kjolson@medicine.wisc.edu) Emma Rolf - (erolf@medicine.wisc.edu) |
| Virginia Commonwealth University Richmond, Virginia | Anya Baranova - (Anna.Baranova2@vcuhealth.org) |
| Wake Forest Baptist Health Winston-Salem, North Carolina | Kimberly Combs - (Kimberly.Combs@Advocatehealth.org) Tarek Zaho, MD - (Tarek.Zaho@Advocatehealth.org) |
| Washington University School of Medicine St Louis, Missouri | Kyle Smith - (kyle.smith1@wustl.edu) Sharon Heuerman - (sheuerman@wustl.edu) |
| Weill Medical College of Cornell University New York, New York | Dolores Reynolds - (dtr2001@med.cornell.edu) |
| Westchester Medical Center Valhalla, New York | Allyson Pulsoni - (allyson.pulsoni@wmchealth.org) Erida Castro-Rivas - (Erida.Castro@wmchealth.org) |
| White Plains Hospital White Plains, New York | Aileen Ferrick - (aferrick@wphospital.org) Uloma Ijomah - (uijomah@wphospital.org) |
| William Beaumont Hospital Royal Oak, Michigan | Lisa Carney - (lisa.carney2@corewellhealth.org) |
| Wooster Community Hospital Wooster, Ohio | Erica Stahl - (estahl@wchosp.org) |
Left vs Left Randomized Clinical Trial
Mihail G Chelu, MD, PhD - leftvsleft@bcm.edu
NCT05650658
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
* Men and women 18 years of age or older.
* A LVEF ≤ 50% within 6 months prior to enrollment.
* Resting QRS duration ≥130 ms as evidenced by a historical 12-lead ECG prior to enrollment OR anticipated right ventricular pacing \>40% OR device in place with right ventricular pacing \> 40%.
* Are optimized on HF guideline directed medical therapy according to current HF published guidelines OR patient's physician will make an effort to start all guideline-directed medical therapy and titrate doses up as permitted by the participant clinical status and co-morbidities prior to implantation procedure.
Exclusion Criteria:
* Women who are pregnant, lactating, or plan to become pregnant during the course of the trial.
* Participants with angiographic evidence of coronary disease who are candidates for coronary revascularization and are likely to undergo coronary artery bypass graft surgery or percutaneous coronary, intervention in the next three (3) months.
* Enzyme-positive myocardial infarction within the past three (3) months prior to enrollment.
* Coronary artery bypass graft surgery or percutaneous coronary intervention (balloon and/or stent angioplasty) within the past three (3) months prior to enrollment.
* Reversible non-ischemic cardiomyopathy (e.g., acute viral myocarditis).
* Participants with Chagas disease, cardiac sarcoidosis or amyloidosis.
* Expected to receive left ventricular assist device or heart transplantation within 6 months.
* Participants with primary severe valvular disease (e.g., aortic stenosis).
* Have a life expectancy of less than 12 months.
* Participants with irreversible brain damage from preexisting cerebral disease.
* Participants with a contrast dye allergy unable or unwilling to undergo pretreatment with steroids and/or diphenhydramine.
* Participants participating in any other interventional cardiovascular clinical trial.
* Participants who would be unable to comply with the study's follow-up visit schedule; or
* Participants who had any prior unsuccessful attempt at implantation of biventricular pacing (BiVP), His Bundle Pacing (HBP), or Left Bundle Branch Pacing (LBBP) device. DEVICE: His/LBBP, DEVICE: BiVP
Heart Failure, Heart Failure With Reduced Ejection Fraction, AV Block, LBBB, RBBB, Intraventricular Conduction Delay, Pacing-Induced Cardiomyopathy
I'm interested
Share via email
Show 71 locations
Study Locations
Hide all locations
| Location | Contacts |
|---|---|
| Allegheny-Singer Research Institute Pittsburgh, Pennsylvania | Minesh Lathia - (minesh.lathia@ahn.org) |
| Baptist Health Louisville Louisville, Kentucky | Karin Cryan - (karin.cryan@BHSI.COM) |
| Baylor College of Medicine Houston, Texas | Stephen Harold - (harold@bcm.edu) |
| Beth Israel Deaconess Medical Center Boston, Massachusetts | Henry Xie - (hxie1@bidmc.harvard.edu) |
| CIS Clinical Research Corporation Naperville, Illinois | |
| CIUSSS de l'Estrie - CHUS Saint-Jean-sur-Richelieu, Quebec | Marie-Claude Grenier - (marie-claude.grenier.ciussse-chus@ssss.gouv.qc.ca) |
| Cleveland Clinic Cleveland, Ohio | Raquel Rozich - (Rozichr@ccf.org) |
| Cleveland Clinic Florida Stuart, Florida | Maria Gomez Mejia - (MEJIAGM@ccf.org) |
| Columbia University Medical Center/New York-Presbyterian Hospital (CUMC/NYPH) New York, New York | Alicha Daniel - (aad2223@cumc.columbia.edu) |
| Florida Heart and Vascular, LLC dba Florida Heart Rhythm Specialist, PLLC South Pasadena, Florida | Adryanna Alban - (adryanna.alban@flahrs.com) |
| Geisinger Commonwealth School of Medicine Scranton, Pennsylvania | |
| HMH Hospitals Corporation Hackensack, New Jersey | Stephanie Lynes - (stephanie.lynes@hmhn.org) |
| Hamilton Health Sciences (HHS) Hamilton, Ontario | Kiran Qamar - (qamarulisl@HHSC.CA) |
| Hartford Hospital Hartford, Connecticut | Saskia Campbell - (Saskia.Campbell@hhchealth.org) |
| Heart Rhythm Solutions Davie, Florida | Daniela Rodriguez - (Daniela@heartrhythmsolutions.com) |
| Icahn School of Medicine at Mount Sinai New York, New York | Ugur Gurol - (Ugur.Gurol@mountsinai.org) |
| Inova Heart and Vascular Institute Falls Church, Virginia | Tracy Plummer - (tracy.plummer@inova.org) |
| Lehigh Valley Hospital Inc. Allentown, Pennsylvania | Traci L Eichelberger - (Traci.Eichelberger@jefferson.edu) |
| Lovelace Medical Center Albuquerque, New Mexico | |
| MH Mission Hospital LLLP- Asheville Cardiology Associates Asheville, North Carolina | Olivia Lim - (olivia.lim@hcahealthcare.com) |
| Massachusetts General Hospital Lexington, Massachusetts | Chris Azzam - (cazzam@MGH.HARVARD.EDU) |
| Mayo Clinic Rochester, Minnesota | Axe M Ahmed - (Ahmed.Abdimajid@mayo.edu) |
| Mazankowski Alberta Heart Institute/University of Alberta Edmonton, Alberta | Lee-Ann Langkaas - (Lee-Ann.Langkaas@albertahealthservices.ca) |
| Medical University of South Carolina (MUSC) Charleston, South Carolina | Olivia Washington - (washoliv@musc.edu) |
| Mercy Gilbert & Chandler Regional Medical Centers, Gilbert AZ Gilbert, Arizona | Jacqueline Killian - (jacqueline.killian@commonspirit.org) |
| Montreal Heart Institute Montreal, Quebec | François François - (Francois.Lemarbre@icm-mhi.org) |
| Mount Sinai Medical Center of Florida, Inc. Miami Beach, Florida | Giselle Cortez - (Giselle.CortezVargas@msmc.com) |
| Newark Beth Israel Medical Center Newark, New Jersey | Patricia Policastro - (Patricia.Policastro@rwjbh.org) |
| Newmarket Electrophysiology Research Group Inc. (NERG) Newmarket, Ontario | Lynn Nyman - (lnyman@southlake.ca) |
| Northwestern University Chicago, Illinois | Katrina Martin - (katrina.martin@nm.org) |
| Nova Scotia Health Authority Halifax, Nova Scotia | Stephanie Hobbs - (Stephanie.hobbs@nshealth.ca) |
| Novant Health Charlotte, North Carolina | |
| Oregon Health & Science University Portland, Oregon | Liz Cannard - (cannarde@ohsu.edu) |
| Penn Medicine Lancaster General Lancaster, Pennsylvania | Andrew Hershey - (Andrew.Hershey@pennmedicine.upenn.edu) |
| Prisma Health-Upstate Greenville, South Carolina | Prisma Health-Upstate Shrum - (ann.shrum@prismahealth.org) |
| Research Institute of the McGill University Health Centre (RI-MUHC) - MUHC, Montreal General Hospital Montreal, | |
| Rush University Chicago, Illinois | |
| Sentara Healthcare Newport News, Virginia | |
| South Denver Cardiology Associates Littleton, Colorado | Kathrin Siegel - (ksiegel@southdenver.com) |
| St. Luke's University Health Network Easton, Pennsylvania | Kyle McFadden - (Kyle.McFadden@sluhn.org) |
| St. Mark's Hospital Salt Lake City, Utah | Pragyna Gundaboina - (Pragyna.Gundaboina@HCAhealthcare.com) |
| Sunnybrook Research Institute Toronto, Ontario | Ambreen Syeda - (ambreen.syeda@sunnybrook.ca) |
| Texas Health Research & Education Institute Arlington, Texas | Rebecca Wade - (rebeccawade@texashealth.org) |
| The Christ Hospital Cincinnati, Ohio | Susanne Pasley - (Susanne.Pasley@thechristhospital.com) |
| The MetroHealth System Cleveland, Ohio | Pete Leo - (pleo@metrohealth.org) |
| The Valley Hospital, Inc. Ridgewood, New Jersey | Lauren Tedeschi - (ltedesc2@Valleyhealth.com) |
| Thomas Jefferson University Hospital Philadelphia, Pennsylvania | |
| Trustees of Indiana University Indianapolis, Indiana | Molly Stearns - (mstearns2@IUHEALTH.ORG) |
| University of Arizona College of Medicine- Phoenix Tucson, Arizona | Raeven Maxwell - (Raeven.Maxwell@bannerhealth.com) |
| University of Arkansas for Medical Sciences (UAMS) Little Rock, Arkansas | Urvashi Kalola - (ukalola@uams.edu) |
| University of British Columbia Vancouver, British Columbia | Munyura Yannick - (yannick.munyura@ubc.ca) |
| University of Calgary Calgary, Alberta | |
| University of California San Diego La Jolla, California | Jesus Gil - (jegil@health.ucsd.edu) |
| University of Chicago Chicago, Illinois | |
| University of Colorado (Anschutz Medical Campus) Denver, Colorado | Tanner Bloks - (tanner.bloks@cuanschutz.edu) |
| University of Florida Jacksonville Jacksonville, Florida | Latonya Been - (latonya.been@ufhealth.org) |
| University of North Carolina Chapel Hill, North Carolina | Elias Wen - (emwen@email.unc.edu) |
| University of Ottawa Heart Institute Ottawa, | Maitreya PATEL - (MaPatel@ottawaheart.ca) |
| University of Pennsylvania Philadelphia, Pennsylvania | Mary Gnap - (Mary.Gnap@pennmedicine.upenn.edu) |
| University of Pittsburg Pittsburgh, Pennsylvania | Sherry Pellegrino - (pellegrinosl@upmc.edu) |
| University of South Florida Tampa, Florida | Jacky He - (jackyhe@usf.edu) |
| University of Vermont Burlington, Vermont | Sonja Baden - (Sonja.Baden@uvmhealth.org) |
| University of Virginia Health System Charlottesville, Virginia | |
| University of Washington Seattle, Washington | Adele Stefanowicz - (amstef99@uw.edu) |
| Université Laval Québec, | Marina Sanchez - (marina.sanchez.1@ulaval.ca) |
| Victoria Cardiac Arrhythmia Trials (VCAT) Inc. Victoria, British Columbia | Matthew Coxon - (mcoxon@catrials.org) |
| Virginia Commonwealth University Richmond, Virginia | |
| Virtua Health Camden, New Jersey | Marisa Brown - (Mbrown3@virtua.org) |
| Waterloo Wellington Cardiovascular Research Institute (WWCRI) - St. Mary's General Hospital Kitchener, | |
| Weill Cornell Medicine New York, New York | Penn Collins - (gpc4001@med.cornell.edu) |
| Yale University New Haven, Connecticut | Meg Leiss - (Margaret.leiss@yale.edu) |
Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator (CARVTOP-ICD)
Mehmet Aktas, M.D. - Mehmet_Aktas@URMC.Rochester.edu
NCT06964464
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
* Age ≥ 18 years
* ICD implanted for primary prevention for HFrEF (either ICM or NICM) with remote monitoring capability
* Current treatment with metoprolol succinate and willing to switch to carvedilol
* LVEF \<50% during the past 12 months prior to consent
Exclusion Criteria:
* Unwilling or unable to follow the protocol
* Treatment with any other ßB than metoprolol succinate or no ßB treatment
* Known prior intolerance or contraindication to carvedilol
* Systolic blood pressure \<100 mmHg
* Enrollment in another clinical trial
* Inability or unwilling to consent DRUG: Metoprolol Succinate, DRUG: Carvedilol
Heart Failure With Reduced Ejection Fraction (HFrEF), Sudden Cardiac Death, Ventricular Arrhythmia, Implantable Cardioverter Defibrillator (ICD), Beta-blocker Therapy, Cardiomyopathy
arrhythmia, heart failure, ICD, implantable cardioverter defibrillator, ICD shock, carvedilol, metoprolol succinate, beta-blocker
I'm interested
Share via email
Show 13 locations
Study Locations
Hide all locations
| Location | Contacts |
|---|---|
| AdventHealth Redmond Rome, Georgia | Charles Jackson, MD - (charles.jackson.md@adventhealth.com) Kathy Jones - (kathy.d.jones@adventhealth.com) |
| AdventHealth Shawnee Mission Shawnee Mission, Kansas | Obadah Al Chekakie, MD - (MObadah.AlChekakie.MD@AdventHealth.com) Megan Kelly - (Megan.Kelly1@adventhealth.com) |
| Christus Trinity Mother Frances Health System Tyler, Texas | Joshua Rutland, MD - (joshua.rutland@christushealth.org) Carol Cushman - (carol.cushman@christushealth.org) |
| Creighton University Medical Center Omaha, Nebraska | Attila Roka, MD - (attilaroka@creighton.edu) Lois A. Rasmussen - (lois.rasmussen@commonspirit.org) |
| Health University of Utah Salt Lake City, Utah | Ravi Ranjan, MD - (ravi.ranjan@hsc.utah.edu) Audra Eaquinto - (audra.eaquinto@hsc.utah.edu) |
| Henry Ford Health System Detroit, Michigan | Waddah Maskoun, MD - (wmaskou1@hfhs.org) Briita Wanhala - (bwanhal1@hfhs.org) |
| HonorHealth Scottsdale, Arizona | Geoffrey Jao, MD - (gjao@honorhealth.com) Mary Futch Moyer - (mfutch@honorhealth.com) |
| New York-Presbyterian Brooklyn Methodist Hospital Brooklyn, New York | Gioia Turitto, MD - (git9006@nyp.org) Shana Hayes, M.S. - (cmc9055@nyp.org) |
| SUNY Downstate Brooklyn, New York | Adam S Budzikowski, MD - (abudzikowski@downstate.edu) Ann Harris - (ann.harris@downstate.edu) |
| University of Mossouri Columbia, Missouri | Brian Bostick, MD - (bostickb@health.missouri.edu) Charles Donigian - (donigianc@health.missouri.edu) |
| University of Rochester Medical Center Rochester, New York | Amole Ojo, MD - (amole_ojo@urmc.rochester.edu) Samantha Delmartino - (samantha_delmartino@urmc.rochester.edu) |
| University of Wisconsin Hospital and Clinics Madison, Wisconsin | Ryan Kipp, MD - (rtkipp@medicine.wisc.edu) Karen Olson - (kjolson@medicine.wisc.edu) |
| Virginia Commonwealth University Richmond, Virginia | Keyur Shah, MD - (keyur.shah@vcuhealth.org) Anna Baranova - (anna.baranova2@vcuhealth.org) |
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Medical Information - medinfo@eidostx.com
NCT06563895
Show full eligibility criteria
Hide eligibility criteria
Key
Inclusion Criteria:
* Male or female ≥ 18 to ≤ 75 years of age inclusive.
* Participants must have an established genotype (hetero- or homozygosity) through a medically-indicated genetic test of a TTR gene variant that is known to be pathogenic or likely pathogenic (eg, V30M/p.V50M, V122I/p.V142I, T60A/p.T80A, or all other pathogenic TTR variants).
* Participant's age is within 10 years younger than or older than PADO.
Key Exclusion Criteria:
* Evidence of ATTR-CM or ATTR-PN.
* Current or past (within last 1 to 12 months, depending on specific agent) treatment with other TTR modifying therapies.
* Contraindication to or inability to undergo cardiac magnetic resonance testing.
* Major organ dysfunction, including: kidney disease, liver disease, heart disease (including cardiomyopathy), neuropathy
* Other diseases or conditions such has cancer within 5 years, untreated hyperthyroidism or hypothyroidism, type 1 diabetes, active hepatitis B or C, HIV.
* Major surgery within the past 3 months or planned during the next 12 months.
* Known hypersensitivity to acoramidis. DRUG: Acoramidis, DRUG: Placebo oral tablet
Amyloidosis, Amyloid Cardiomyopathy, Transthyretin Amyloidosis, Cardiomyopathies, Heart Diseases, Polyneuropathies
Amyloidosis, ATTR-CM, ATTR-PN, Transthyretin, Amyloid, TTR
I'm interested
Share via email
Show 104 locations
Study Locations
Hide all locations
| Location | Contacts |
|---|---|
| AP-HP Hopital Bicetre Le Kremlin-Bicêtre, | |
| AP-HP Hopital Henri Mondor Paris, | |
| Aarhus University Hospital Aarhus, | |
| Azienda Ospedaliero Universitaria Policlinico Umberto I Roma, | |
| Azienda Ospedaliero-Universitaria Careggi Florence, | |
| Azienda Ospedaliero-Universitaria Sant'Andrea Rome, | |
| Azienda Ospedaliero-Universitaria di Bologna IRCCS Policlinico di S.Orsola Bologna, | |
| Boston University (BU) School of Medicine Boston, Massachusetts | |
| Brigham and Women's Hospital Boston, Massachusetts | |
| CAPED - Centro Avancado de Pesquisa, Estudos e Diagnostico Ribeirão Preto, | |
| CHU Bordeaux - Hopital Pellegrin Bordeaux, | |
| CHU de Fort de France Fort-de-France, | |
| CHU de Toulouse - Hopital Rangueil Toulouse, | |
| Cardiopulmonar da Bahia S.A. (Hospital Cardio Pulmonar) Salvador, | |
| Changhua Christian Hospital - Taiwan Changhua, | |
| Charite Universitaetsmedizin Berlin Berlin, | |
| Chu Rennes Rennes Cedes, | |
| Cleveland Clinic Cleveland, Ohio | |
| Cleveland Clinic Florida Stuart, Florida | |
| Columbia University Medical Center New York, New York | |
| Duke University Medical Center Durham, North Carolina | |
| Emory University School Of Medicine Atlanta, Georgia | |
| Erasmus MC Rotterdam, | |
| Fiona Stanley Hospital Murdoch, Western Australia | |
| Fondazione IRCCS Policlinico San Matteo Pavia, | |
| Fondazione Policlinico Universitario A. Gemelli IRCCS - Universita Cattolica del Sacro Cuore Rome, | |
| Fondazione Toscana Gabriele Monasterio per la Ricerca Medica e di Sanità Pubblica - Ospedale San Cataldo Pisa, | |
| Fundacao Centro Medico de Campinas Campinas, | |
| General Hospital of Athens - Alexandra Athens, | |
| HIPPOKRATION General Hospital of Athens Athens, | |
| Henry Ford Health System Detroit, Michigan | |
| Hospital Britanico de Buenos Aires Ciudad de Buenos Aires, Buenos Aires | |
| Hospital Clinico Universitario de Salamanca Salamanca, | |
| Hospital Universitari de Bellvitge L'Hospitalet de Llobregat, | |
| Hospital Universitario Juan Ramon Jimenez Huelva, | |
| Hospital Universitario Puerta de Hierro Majadahonda, | |
| Hospital Universitario Son Llatzer Palma de Mallorca, | |
| Hospital Universitario de A Coruna A Coruña, | |
| ICBA - Instituto Cardiovascular de Buenos Aires S.A. CABA, | |
| Inova Fairfax Hospital Falls Church, Virginia | |
| Instituto do Coracao (InCor) do Hospital das Clinicas da FMUSP Cerqueira César, | |
| John H. Stroger, Jr. Hospital of Cook County Chicago, Illinois | |
| Johns Hopkins University Baltimore, Maryland | |
| Kumamoto University Hospital Kumamoto-Shi Chuo-Ku, Kumamoto | |
| Laurelton Heart Specialists Rosedale, New York | |
| Maastricht University Medical Center Maastricht, | |
| Massachusetts General Hospital Lexington, Massachusetts | |
| Mayo Clinic - Jacksonville Jacksonville, Florida | |
| Mayo Clinic - Rochester Rochester, Minnesota | |
| MedStar Washington Hospital Center - MedStar Heart and Vascular Institute Washington D.C., District of Columbia | |
| Medical University of South Carolina (MUSC) Charleston, South Carolina | |
| Mount Sinai Hospital New York, New York | |
| National Institute of Medical Sciences and Nutrition - Salvador Zubiran(INCMNSZ) Tlalpan, | |
| National Neuromuscular Research Institute Austin, Texas | |
| National Taiwan University Hospital Taipei, | |
| National University Hospital - National University Health System Singapore, | |
| New York University (NYU) School of Medicine - Langone Medical Center New York, New York | |
| Norrlands universitetssjukhus (University Hospital of Umea) Umeå, | |
| Oregon Health & Science University Portland, Oregon | |
| Penn Presbyterian Medical Center Philadelphia, Pennsylvania | |
| Princess Alexandra Hospital Woolloongabba, Queensland | |
| Prisma Health Cancer Institute Greenville, South Carolina | |
| Rutgers-Robert Wood Johnson Medical School New Brunswick, New Jersey | |
| Samsung Medical Center Seoul, | |
| Seoul National University Hospital Seoul, | |
| Seoul St. Mary's Hospital Seoul, | |
| Severance Hospital, Yonsei University Health System Seoul, | |
| Shinshu University Hospital Nagano, Matsumoto, | |
| Singapore General Hospital Singapore, | |
| St Vincent's Hospital Sydney Darlinghurst, New South Wales | |
| St. Bartholomew's Hospital London, | |
| St. Luke's Hospital of Kansas City Kansas City, Missouri | |
| St. Michael's Hospital Toronto, Ontario | |
| Stanford University Stanford, California | |
| Taipei Veterans General Hospital Taipei, | |
| Tallaght University Hospital - The Adelaide and Meath Hospital Dublin, | |
| The Mater Misericordiae University Hospital Dublin, | |
| UZ Leuven Leuven, | |
| Unidade Local de Saude de Santa Maria EPE - Hospital de Santa Maria Lisbon, | |
| Unidade Local de Saude de Santo Antonio EPE - Hospital de Santo Antonio Porto, | |
| UniversitaetsKlinikum Heidelberg Heidelberg, | |
| Universitaetsmedizin der Johannes Gutenberg - Universitaet Mainz Mainz, | |
| Universitair Medisch Centrum Utrecht Utrecht, | |
| University College London Hospitals NHS Foundation Trust London, | |
| University Malaya Medical Centre (UMMC) Kuala Lumpur, | |
| University Medical Center Groningen Groningen, | |
| University of British Columbia Vancouver, British Columbia | |
| University of Calgary Calgary, Alberta | |
| University of California, Los Angeles (UCLA) - David Geffen School of Medicine Los Angeles, California | |
| University of California, San Diego (UCSD) - Medical Center La Jolla, California | |
| University of California, San Francisco (UCSF) San Francisco, California | |
| University of Chicago - Medical Center Chicago, Illinois | |
| University of Colorado Anschutz Aurora, Colorado | |
| University of Maryland Medical Center Baltimore, Maryland | |
| University of Miami Miami, Florida | |
| University of Pittsburgh Medical Center, Presbyterian Hospital Pittsburgh, Pennsylvania | |
| University of Texas Southwestern Dallas, Texas | |
| University of Utah Salt Lake City, Utah | |
| University of Washington Medical Center Seattle, Washington | |
| Virginia Commonwealth University Richmond, Virginia | |
| Washington University in St. Louis St Louis, Missouri | |
| Westmead Hospital Northmead, New South Wales | |
| Yale University School of Medicine - Section of Cardiology New Haven, Connecticut | |
| hospital Italiano de Buenos Aires CABA, |
His-Bundle Corrective Pacing in Heart Failure (HIS-CRT)
Ann Colasurdo - ann.colasurdo@heart.rochester.edu
NCT05265520
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
* Age 18 years or older (no upper age limit)
* Optimal medical therapy for heart failure by current guidelines
* Class IIa or IIb guideline-based indication for CRT-D implant in RBBB patients, including one of the following:
* New York Heart Association (NYHA) class II HF symptoms, LVEF ≤ 30% and QRS≥ 150 ms (IIb); OR
* NYHA class III-IV a HF, LVEF ≤ 35%, and QRS duration ≥ 150 ms (IIa); OR
* NYHA class III-IV a HF, LVEF ≤ 35%, and QRS duration 120-149 ms (IIb)
Exclusion Criteria:
* Unable to obtain most recent imaging data from echocardiogram within 1 year prior to date of randomization
* Left bundle branch block (LBBB) or intraventricular conduction delay (IVCD) ECG morphology
* Unable or unwilling to follow study protocol
* Less than 12 months life expectancy at consent
* Pregnancy or planned pregnancy during duration of the study
* On heart transplant list or likely to undergo heart transplant PROCEDURE: His-CRT implantation, PROCEDURE: BIV-CRT implantation
Right Bundle-Branch Block, Heart Failure, His-bundle Pacing, Cardiac Resynchronization Therapy
I'm interested
Share via email
Show 14 locations
Study Locations
Hide all locations
| Location | Contacts |
|---|---|
| Cedars-Sinai Medical Center Los Angeles, California | |
| Geisinger Wyoming Valley Wilkes-Barre, Pennsylvania | |
| Mission Health Asheville, North Carolina | |
| Mount Sinai Hospital New York, New York | |
| Northwestern Memorial Hospital Chicago, Illinois | |
| Rush University Medical Center Chicago, Illinois | |
| University of Arizona Tucson, Arizona | |
| University of Chicago Chicago, Illinois | |
| University of Pennsylvania Philadelphia, Pennsylvania | |
| University of South Florida Tampa, Florida | |
| University of Vermont Burlington, Vermont | |
| Valley Health System Ridgewood, New Jersey | |
| Virginia Commonwealth University Richmond, Virginia | |
| Weill Cornell Medical College New York, New York |
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity (HF-POLARIS)
Novo Nordisk - clinicaltrials@novonordisk.com
NCT07567001
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
* Body Mass Index (BMI) greater than or equal to (\>=) 30 kilograms per square metre (kg/m\^2) at screening.
* Diagnosis of HF with New York Heart Association (NYHA) class II-IV and in stable condition at screening, at the discretion of the investigator.
For participants with Type 2 Diabetes (T2D) at screening:
\- Diagnosed with T2D \>= 30 days before screening.
Exclusion Criteria:
* MI, stroke, unstable angina pectoris or worsening HF leading to either hospitalization or intravenous loop diuretics within 30 days prior to the day of screening and until randomization.
* HF due to infiltrative cardiomyopathy (e.g., sarcoid, amyloid), arrhythmogenic right ventricular cardiomyopathy, Takutsubo cardiomyopathy, Chagas cardiomyopathy, genetic hypertrophic cardiomyopathy or obstructive cardiomyopathy, active myocarditis, constrictive pericarditis, cardiac tamponade, or uncorrected primary valve disease of moderate or severe degree.
* Severe pulmonary disease including primary pulmonary hypertension, chronic pulmonary embolism, or severe chronic obstructive pulmonary disease (COPD) defined as:
* requiring home oxygen; or - ongoing oral corticosteroid therapy; or - hospital for COPD Exacerbation within 12 months prior to screening.
* Any other condition judged by the investigator to be the cause of HF symptoms (e.g., anaemia, hypothyroidism).
Glycaemia-related:
* History of type 1 diabetes.
* Participant with diabetic retinopathy or maculopathy who received treatment with retinal photocoagulation, vitrectomy or anti-Vascular Endothelial Growth Factor (anti-VEGF) within 180 days before screening or who, at the time of screening, are expected to require treatment within 180 days after screening. Diabetic retinopathy or maculopathy must be verified by an eye examination performed within 90 days before screening or in the period between screening and randomization. Pharmacological pupil-dilation is a requirement unless using a digital fundus photography camera specified for non-dilated examination.
* Glycated haemoglobin (HbA1c) greater than (\>) 10 percent (%) (86 \[millimoles per mole\] mmol/mol) as measured by local or central laboratory at screening. DRUG: NNC0487-0111, DRUG: Placebo
Obesity, Heart Failure
I'm interested
Share via email
Show 838 locations
Study Locations
Hide all locations
| Location | Contacts |
|---|---|
| "AHEPA" University General Hospital of Thessaloniki Thessaloniki, | |
| "Hygeia" General Hospital of Athens Athens, | |
| 'G. Gennimatas' General Hospital of Athens - Cardiology Department Athens, | |
| 'Ippokrateio' General Hospital of Thessaloniki Thessaloniki, | |
| 251 Air Force General Hospital - Department of Endocrinology & Diabetes Athens, | |
| 4 Wojskowy Szpital Kliniczny Z Poliklinika Samodzielny Publiczny Zaklad Opieki Zdrowotnej We Wroclawiu Wroclaw, Lower Silesian Voivodeship | |
| AHEPA General University Hospital Thessaloniki, | |
| AIPSCMC - Dr. Nikolay Iliev EOOD Pleven, | |
| AIPSMCIDC - Dr. Georgi Nedyalkov EOOD Plovdiv, | |
| AOU Bologna - Malpighi - Dipartimento Medicina Interna Bologna, Emilia-Romagna | |
| AOU Federico II Di Napoli - DAI di Medicina Interna e della Complessità Clinica Naples, Campania | |
| AOU Perugia - Santa Maria della Misericordia - S. C. Medicina Interna Perugia, Umbria | |
| AOU Sassari - UOC Cardiologica Clinica ed Interventistica Sassari, | |
| APHP - HOPITAL BICETRE_Service de Cardiologie Le Kremlin-Bicêtre, | |
| ASSL Sette Laghi - Ospedale Galmarini di Tradate Varese, Lombardy | |
| ASST Papa Giovanni XXIII - Cardiologia 1 Bergamo, Lombardy | |
| Accellacare Wilmington Wilmington, North Carolina | |
| Acibadem City Clinic UMHAT EOOD, Cardiology Sofia, | |
| Adana Şehir Eğitim ve Araştırma Hastanesi Adana, | |
| Adana Şehir Eğitim ve Araştırma Hastanesi-Dahiliye Yuregir/Adana, | |
| Adrian Costa Clinical Trials Centre Geelong, Victoria | |
| Advanced Cardiology LLC - Hackettstown Hackettstown, New Jersey | |
| Advanced Cardiovascular, LLC Alexander City, Alabama | |
| Advanced Medical Research Maumee, Ohio | |
| Advara HeartCare Joondalup Joondalup, Western Australia | |
| Advara HeartCare Leabrook Leabrook, South Australia | |
| Advara HeartCare Mulgrave Mulgrave, Victoria | |
| Adventist Healthcare Shady Grove Medical Center Rockville, Maryland | |
| Aesculap Ambulance s.r.o. Dolní Břežany, | |
| Afyonkarahisar Sağlık Bilimleri Üniversitesi Sağlık Uygulama Ve Araştırma Merkezi- Kardiyoloji Afyonkarahisar, | |
| Aintree University Hospital Liverpool, | |
| Ajou University Hospital_Cardiology Suwon, Gyeonggi-do | |
| Akdeniz Üniversitesi Hastanesi-Kardiyoloji Antalya, | |
| Al-Zoebi Wermsdorf, | |
| Alexandra General Hospital, Therapeutic Clinic Athens, Attica | |
| All India Institute of Medical Sciences (AIIMS) New Delhi, National Capital Territory of Delhi | |
| All India Institute of Medical Sciences (AIIMS), Bhubaneswar Bhubaneswar, Odisha | |
| All India Institute of Medical Sciences (AIIMS), Nagpur Nagpur, Maharashtra | |
| Alrijne Leiderdorp - Cardiologie Leiderdorp, | |
| American Clinical Trials, LLC Acworth, Georgia | |
| American Heart of Poland S.A. Tychy, | |
| American Heart of Poland S.A. Tychy, | |
| American Heart of Poland S.A. Tychy, | |
| Amicis Centers of Clinical Research St Louis, Missouri | |
| Amicis Research Center Northridge, California | |
| Amicis Research Center Northridge, California | |
| Amphia Ziekenhuis Breda, | |
| Amrita Institute of Medical Sciences Kochi, Kerala | |
| AmsterdamUMC AMC Amsterdam, | |
| Anderson Medical Group Ft. Washington, Maryland | |
| Ankara Bilkent Şehir Hastanesi-Dahiliye Ankara, | |
| Ankara Bilkent Şehir Hastanesi-Kardiyoloji Ankara, | |
| Ankara Etlik Şehir Hastanesi- Kardiyoloji Yenimahalle/Ankara, | |
| Antalya Eğitim ve Araştırma Hastanesi- Kardiyoloji Muratpasa/ Antalya, | |
| Arcispedale S. Maria Nuova - U.O.C. Cardiologia Reggio Emilia, Emilia-Romagna | |
| Arcispedale Sant'Anna (Cona) - Dipartimento Interaziendale Cardio-toraco-vascolare Ferrara, Emilia-Romagna | |
| Arizona Research Center Phoenix, Arizona | |
| Arkansas Health Group Little Rock, Arkansas | |
| Arneja Heart & Multispeciality Hospital Nagpur, Maharashtra | |
| Arrow Clinical Trials Daytona Beach, Florida | |
| Asan Medical Center_Cardiology Seoul, | |
| Ascension Saint Agnes Heart Ca Baltimore, Maryland | |
| Asha Clinical Rsch-Munster, LLC Hammond, Indiana | |
| Asklepieion General Hospital - Cardiology Clinic Athens/Voula, | |
| Asklepios Klinik Langen - Medizinische Klinik I Langen, | |
| Associacao Beneficente Siria - HCOR São Paulo, São Paulo | |
| Associação Lar São Francisco de Assis na Providência de Deus - Bragança Paulista Bragança Paulista, São Paulo | |
| Assuta Ashdod MC - The Institute of Cardiology Ashdod, | |
| Aster Medcity Kochi, Kerala | |
| Atatürk Üniversitesi Araştırma Hastanesi-Kardiyoloji Yakutiye / Erzurum, | |
| Athens Medical Center S.A (Iatriko Athinon) - Cardiology Clinic Athens, | |
| Athens Medical Center S.A. (Iatriko Peristeriou) - Diabetes, obesity and cardiometabolic diseases department Peristeri, | |
| Athens Medical Center S.A., European Interbalkan Medical Center - Department of Internal Medicine Thessaloniki, | |
| Atlanta Center for Clinical Research_Atlanta Atlanta, Georgia | |
| Atlanta Heart Specialists, LLC Tucker, Georgia | |
| AtlantiCare Regional Medical Center Pomona, New Jersey | |
| Augustinerinnen KHs - Cellitinnen KH Köln Cologne, | |
| Aultman Hospital Canton, Ohio | |
| Aurora St. Luke's Medi Ctr Milwaukee, Wisconsin | |
| Austin Heart Austin, Texas | |
| Austin Heart Austin, Texas | |
| Azienda Ospedaliera Padova - UOC Clinica Medica 3 Padova, Veneto | |
| Azienda Ospedaliera Policlinico Universitario Tor Vergata - UOC Cardiologia Rome, Lazio | |
| Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone - U.O. Cardiologia Palermo, Sicily | |
| Azienda Ospedaliero - Universitaria Sant'Andrea - UOC Medicina interna Rome, Lazio | |
| Azienda Ospedaliero Universitaria Pisana - U.O. Medicina 1 Pisa, Tuscany | |
| Azienda Ospedaliero-Universitaria Senese - Dipartimento Cardio-toraco-vascolare Siena, Tuscany | |
| Baker-HeartWest - Hoppers Crossing Hoppers Crossing, Victoria | |
| Balad Hlth Sys-Welmont CardCVA Greeneville, Tennessee | |
| Balticmed Świnoujście Sp. z o. o. Świnoujście, | |
| Baotou City Central Hospital-Cardiology Baotou, Inner Mongolia | |
| Barnet Hospital - Cardiology Department Barnet, | |
| Batra Hospital and Medical Research Center New Delhi, National Capital Territory of Delhi | |
| BayCare Health System Tampa, Florida | |
| Baylor Scott & White Health Temple, Texas | |
| Baylor Scott & White Health Temple, Texas | |
| Baylor Scott & White Health Temple, Texas | |
| Baylor Scott & White Res Inst Plano, Texas | |
| Bella Vita Clinical Research Cape Town, Western Cape | |
| Biopharma Informatic, LLC McAllen, Texas | |
| Blue Coast Research Center Vista, California | |
| Bnai Zion MC - Department of Cardiology Haifa, | |
| Bravis Zkh Roosendaal Roosendaal, | |
| Broward Research Ctr. Miami Beach, Florida | |
| Broward Research Ctr. Miami Beach, Florida | |
| Bryan Heart Lincoln, Nebraska | |
| Bursa Yüksek İhtisas Eğitim ve Araştırma Merkezi-Kardiyoloji Bursa, | |
| C.I.C. Joliette Saint-Charles-Borromée, Quebec | |
| CAICI Rosario, | |
| CAPED - Centro Avançado de Pesquisa, Estudos e Diagnósticos Ribeirão Preto, São Paulo | |
| CC LIFE s.r.o. Brno, | |
| CCECB _Cabinet de Cardiologie ALDAPA Bayonne, | |
| CCIH-Consultoria em Controle de Infecção Hospitalar Ltda Belo Horizonte, Minas Gerais | |
| CEDIC Centro de Investigación Clínica CABA, | |
| CEDIR - Centro de diagnóstico y rehabilitación Santa Fe Santa Fe, | |
| CEMEDIC CABA, | |
| CENTRE HOSPITALIER DE CHOLET_Service de Cardiologie Cholet, | |
| CENTRE HOSPITALIER DE VERSAILLES-HOPITAL ANDRE MIGNOT_Service de Cardiologie Le Chesnay, | |
| CH LA ROCHELLE - Service de Cardiologie La Rochelle, | |
| CHI Franciscan Research Center Tacoma, Washington | |
| CHI TOULON - HOPITAL SAINTE MUSSE_Service de Cardiologie Toulon, | |
| CHRU BREST - HOPITAL DE LA CAVALE BLANCHE_Service de cardiologie Brest, | |
| CHRU NANCY - HOPITAL BRABOIS_Service de Cardiologie Vandœuvre-lès-Nancy, | |
| CHRU TOURS - HOPITAL TROUSSEAU - Service de Cardiologie Chambray-lès-Tours, | |
| CHU NANTES - HOPITAL NORD LAENNEC_Service d'Endocrinologie-Diabétologie-Nutrition Saint-Herblain, | |
| CHU NIMES - HOPITAL CAREMEAU_Service de Cardiologie Nîmes, | |
| CHU de Quebec-Uni Laval-Hotel Québec, | |
| CHUM-Hosp de Univ Montreal Montreal, Quebec | |
| CIMAB SA de CV Torreón, Coahuila | |
| CIPES - Centro Internacional de Pesquisa Clínica LTDA São José dos Campos, São Paulo | |
| CISSS BAS ST-LAURENT, HOPITAL regional DE RIMOUSKI Rimouski, Quebec | |
| CIUSSS du Saguenay-Lac-St-Jean Chicoutimi, Quebec | |
| CLINIQUE DU MILLENAIRE_Service de Cardiologie Interventionelle Montpellier, | |
| CMC Cardiología Sociedad Simple San Miguel de Tucumán, | |
| CPQuali Pesquisa Clinica Ltda São Paulo, São Paulo | |
| CPS Research Waterloo, Ontario | |
| California Heart Specialist Huntington Beach, California | |
| Canberra Hospital - Clinical Trials Unit Canberra, Australian Capital Territory | |
| Capital Cardiology Associates_Albany Albany, New York | |
| Card Specialists of Willowbrook Houston, Texas | |
| CardiaMet Ciudad Autonoma de Buenos Aires, Buenos Aires | |
| Cardiac Clinical Research Unit, University of Cape Town Cape Town, Western Cape | |
| Cardiac Institute for Research at Queen's - CIRQ Kingston, Ontario | |
| Cardiac Vascular Sentral Kuala Lumpur Kuala Lumpur, Kuala Lumpur | |
| Cardio Health Clinical Trials Kitchener, | |
| Cardio Innovation & Resch Ctr Long Beach, California | |
| Cardio Metabolic Institute Somerset, New Jersey | |
| Cardio Research & Education Foundation Wausau, Wisconsin | |
| Cardio Research of S. Cal Beverly Hills, California | |
| Cardio Research s.r.o. Zlín, | |
| Cardio and Vascular Assoc-CAVA Bloomfield Hills, Michigan | |
| CardioConsil GmbH Rostock, | |
| Cardiologicum Dresden und Pirna - MVZ "Am Felsenkeller" (Dresden) Dresden, | |
| Cardiología Hospital J. M. Ramos Mejia Buenos Aires, | |
| Cardiología Palermo City of Buenos Aires, Buenos Aires | |
| Cardiovascular Consultants of South Georgia Thomasville, Georgia | |
| Cardiovascular Institute of Orlando Orlando, Florida | |
| Cardiovascular Institute of the South Houma, Louisiana | |
| Cardiovascular Institute of the South Houma, Louisiana | |
| Care Access Research Easton, Pennsylvania | |
| Care United Research, LLC Forney, Texas | |
| Carient Heart and Vascular Manassas, Virginia | |
| Catharina Zkh Eindhoven - Cardiologie Eindhoven, | |
| Cbk Med Clinic Sp. z o.o. Płock, Masovian Voivodeship | |
| Centro Cardiovascular Salta Salta, | |
| Centro Medico Capital La Plata, Buenos Aires, | |
| Centro Medico Dra. Laura Maffei e Investigacion Clínica Apli Buenos Aires, | |
| Centro Médico CIMEL Lanús Este, Buenos Aires | |
| Centro Médico Luquez Córdoba, | |
| Centro de Atención al Diabético Actopan (CAD) Actopan, Hidalgo | |
| Centro de Atención e Investigación Cardiovascular del Potosi (CICAP) San Luis Potosí City, | |
| Centro de Investigaciones Clinica Baigorria Santa Fe, Santa Fe Province | |
| Centro de Investigaciones Clinicas del Litoral Santa Fe, | |
| Centro de Investigaciones Metabólicas Capital Federal, | |
| Centro de Investigación Integral MEDIVEST Chihuahua City, | |
| Centro de Investigación y Control Metabólico S. C. San Nicolás de los Garza, Nuevo León | |
| Centro de Pesquisa Silvestre Santé Rio Branco, Acre | |
| Centro de Pesquisas Clínicas Dr. Marco Mota LTDA Maceió, Alagoa | |
| Centrum Medyczne "Hipokrates" s.c. Elżbieta i Grzegorz Grześk Bydgoszcz, | |
| Centrum Medyczne Kermed Renata Bijata-Bronisz I Ewa Kowalinska Sp. j. Bydgoszcz, | |
| Centrum Medyczne Komorniki Sp. z o.o. Komorniki, | |
| Centrum Medyczne MBB-MED Marta Blach-Burek Libiąż, | |
| Centrum Medyczne MBB-MED Marta Blach-Burek Libiąż, | |
| Centrum Medyczne Ogrodowa Sp. z o.o. Lowicz, | |
| Chambersburg Hospital Chambersburg, Pennsylvania | |
| Chang Gung Memorial Hospital - Kaohsiung Branch Kaohsiung City, | |
| Chang Gung Memorial Hospital, Linkou Taoyuan City, | |
| Changsha Central Hospital-Cardiovascular Medicine Changsha, Hunan | |
| Changzhou No.2 People's Hospital-Cardiology Changzhou, Jiangsu | |
| Charité - Campus Virchow-Klinikum - Kardiologie, Angiologie und Intensivmedizin (CRU) Berlin, | |
| Chesterfield Royal Hospital Chesterfield, | |
| Chicago Clinical Research Institute INC Orland Park, Illinois | |
| Chicago Clinical Research Institute INC Orland Park, Illinois | |
| Chicago Medical Research LLC Hazel Crest, Illinois | |
| China-Japan Union Hospital of Jilin University-Cardiology Changchun, Jilin | |
| Chonnam National University Hospital_Cardiology Gwangju, | |
| Chungnam National University Hospital_Cardiology Daejeon, | |
| Circulate Cardiac and Vascular Centre Burlington, Ontario | |
| Clalit HMO Holon Holon, | |
| Clearwater Cardiovascular Consultants Clearwater, Florida | |
| Clindove Research Brooklyn, New York | |
| Clinical Medical Research Sp. z o.o. Katowice, | |
| Clinical Research Consultants, JCCT Co Kansas City, Missouri | |
| Clinical Research Institute of South Africa KwaDukuza, KwaZulu-Natal | |
| Clinical Trial Systems (CTC) Pretoria, Gauteng | |
| Clinical Trials Network Helderberg (Pty) Ltd Somerset West, Western Cape | |
| Clinique Saint Augustin Bordeaux, | |
| Clinresco Centres (Pty) Ltd Kempton Park, Gauteng | |
| Clinstile S.A. de C.V. Col Roma Norte, Mexico City | |
| Clínica Privada Velez Sarsfield Córdoba, | |
| Colorado Heart and Vascular PC Golden, Colorado | |
| Columbia University Medical Center_New York New York, New York | |
| Complejo Hospitalario Universitario A Coruna A Coruña, | |
| Conquest Research Winter Park, Florida | |
| Consultorio 1020 Hospital Angeles Xalapa Xalapa, Veracruz | |
| Consultorio Dr. Eduardo Chuquiure Tlalpan, Mexico City | |
| Consultorio Privado Dr Gabriel Arturo Ramos Guadalajara, Jalisco | |
| Consultorio Privado Dr. Francisco Padilla Guadalajara, Jalisco | |
| Corcare Cardiovascular Research Scarborough Village, Ontario | |
| Core Research Group Brisbane, | |
| Corewell Health Royal Oak, Michigan | |
| Craigavon Area Hospital - Cardiovascular Research Unit Craigavon, | |
| Crescent Hospital And Heart Centre Nagpur, Maharashtra | |
| Curnew Medicine Professional Corporation Hamilton, Ontario | |
| DAI Scienze Mediche - UOC Medicina Interna Angiologia e Malattie Aterosclerotiche Messina, Sicily | |
| DBC Research - Pembroke Pines Pembroke Pines, Florida | |
| DCC 1 - Lom EOOD Lom, | |
| DCC Aleksandrovska EOOD Sofia, | |
| DCC Convex EOOD Sofia, | |
| Dallas Heart and Vascular Duncanville, Texas | |
| David Turbay, MD, PLLC El Paso, Texas | |
| Dayanand Medical College & Hospital Ludhiana, Punjab | |
| Deenanath Mangeshkar Hospital & Research Centre Pune, | |
| Derriford Hospital Plymouth, | |
| Desert Oasis Healthcare Palm Springs, California | |
| Diabetes Heart Research Centre Toronto, Ontario | |
| Diakonessenhuis Utrecht - Cardiologie Utrecht, | |
| Diex Recherche Sherbrooke Sherbrooke, Quebec | |
| Diex Recherche Trois-Rivieres Trois-Rivières, Quebec | |
| Dokuz Eylül Üniversitesi Araştırma Uygulama Hastanesi-Kardiyoloji Izmir, | |
| Dorset County Hospital Dorchester, Dorset | |
| Doylestown Heath cardiology Doylestown, Pennsylvania | |
| Dr A Jacovides and Partners Inc Midrand, Gauteng | |
| Dr Hendrik Snyman's Practice Mossel Bay, Western Cape | |
| Dr IO Ebrahim Inc Pretoria, Gauteng | |
| Dr MT Makhomisane Inc Polokwane, | |
| Dr Pillay's Rooms Durban, KwaZulu-Natal | |
| Dr. Siyami Ersek Göğüs Kalp ve Damar Cerrahisi EAH- Kardiyoloji Istanbul, | |
| Duke University Durham, North Carolina | |
| EKAMED sp. z o.o. Lublin, Lublin Voivodeship | |
| Eagle Clinical Research Chicago, Illinois | |
| East Atlanta Cardiology Conyers, Georgia | |
| East Rand Physicians Clinical Research Division (Pty) Ltd Benoni, Gauteng | |
| East Texas Cardiology PA Houston, Texas | |
| Eastbourne Distirct General Hospital - Cardiology Eastbourne, | |
| Eastern Shore Rsrch Inst, LLC Fairhope, Alabama | |
| Edumed s.r.o. Náchod, | |
| Edumed s.r.o. Náchod, | |
| Elkerliek Ziekenhuis - Cardiologie Helmond, | |
| Empire Clin. Research Pomona, California | |
| Endolife Specialty Hospitals Guntur, Andhra Pradesh | |
| Erciyes Üniversitesi Hastanesi- Kardiyoloji Kayseri, | |
| Eskişehir Osmangazi Üniversitesi Hastanesi- Kardiyoloji Eskişehir, Odunpazari | |
| Eskişehir Şehir Hastanesi- Kardiyoloji Odunpazarı /Eskişehir, | |
| Eurolatino Medical Research Center Uberlândia, Minas Gerais | |
| FOMAT Medical Research Oxnard, California | |
| Facharztzentrum Dresden Betriebsgesellschaft mbH Dresden, | |
| Fakultni nemocnice Brno Brno, | |
| Fakultni nemocnice Olomouc Olomouc, Olomouc Region | |
| Fakultni nemocnice u sv. Anny v Brne Brno, | |
| Flinders Medical Centre - Cardiology Department Bedford Park, South Australia | |
| Flourish Research Bowie Bowie, Maryland | |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Dipartimento di Scienze Cardiovascolari Rome, Lazio | |
| Forschungszentrum Ruhr KliFoCenter GmbH, Kahrmann Witten, | |
| Fortis Hospital, Mohali Mohali, | |
| Fortis Memorial Research Institute _Gurgaon Gurugram, Haryana | |
| Franciscus Gasthuis en Vlietland - Cardiologie Rotterdam, | |
| Frederiksberg Hospital - Hjertemedicinsk afdeling Y Frederiksberg, | |
| Fukuoka Wajiro Hospital_Cardiology Fukuoka-shi, Fukuoka, | |
| Fukuokaken Saiseikai Futsukaichi Hospital_Cardiovascular Medicine Chikushino-shi, Fukuoka, | |
| Fundacion Respirar Ciudad Autónoma de Buenos Aires, Buenos Aires | |
| Fundação Faculdade Regional de Medicina de São José do Rio Preto São José do Rio Preto, São Paulo | |
| Future Life Clinical Trials Miami, Florida | |
| Futuremeds Sp. z o.o. Wroclaw, | |
| Fırat Üniversitesi Hastanesi- Kardiyoloji Merkez/elaziğ, | |
| G B Pant Institute of Postgraduate Medical Education and Research New Delhi, National Capital Territory of Delhi | |
| G&J Research San Diego, California | |
| G.A. Research Associates Ltd. Moncton, New Brunswick | |
| Gachon University Gil Medical Center_Cardiology Incheon, | |
| Galaxy Life Care Services Pvt. Ltd Varanasi, Uttar Pradesh | |
| Gangnam Severance Hospital_Cardiology Seoul, | |
| Gelderse Vallei - Cardiologie Ede, | |
| Gemeinschaftspraxis Faghih-Friedrichs-Zühlke Essen, | |
| Gemeinschaftspraxis Melcherstätte - Dr. L. Pohlmeier, T. Drescher Stuhr, | |
| General Hospital Venizeleio-Pananeio - Cardiology department Heraklion, | |
| General Hospital of Athens "Elpis" - Cardiology Department Ampelokipoi/Athens, | |
| General Hospital of Athens "Laiko" Athens, Attikí | |
| General Hospital of Chalkida - Cardiology department Chalcis, | |
| General Hospital of Chios "Skilitsio" - Cardiology Clinic Chios, | |
| General Hospital of Kalamata - Cardiology Department Chalcis, | |
| General Hospital of Thessaloniki "G.Papanikolaou" Thessaloniki, | |
| George Eliot Hospital Nuneaton, Warwickshire | |
| Gesundheitscentrum Mainz (Regner / Schmitt) Mainz, | |
| Glan Clwyd Hospital - North Wales Cardiac Centre Rhyl, Denbighshire | |
| Glenfield Hospital - Cardiovascular Research Leicester, | |
| Glenny Corp. S.A CABA, | |
| Government Siddhartha Medical College & Government General Hospital, Vijayawada Vijayawada, Andhra Pradesh | |
| Grace Research, LLC Bossier City, Louisiana | |
| Grace Research, LLC_Shreveport Shreveport, Louisiana | |
| Groene Hart Zkh Gouda - Cardiologie Gouda, | |
| Grupo AngioKormann Blumenau, Santa Catarina | |
| Guangdong Provincial People's Hospital-Cardiovascular Guangzhou, Guangdong | |
| Guardian Research Org LLC Winter Park, Florida | |
| Gunma University Hospital_Cardiovascular Medicine Maebashi-shi, Gunma, | |
| Gyncentrum Sp. z o. o. Katowice, | |
| Gülhane Eğitim ve Araştırma Hastanesi- Kardiyoloji Keçiören/Ankara, | |
| H Virgen del Camino_Sanlúcar_Medicina Interna Sanlúcar de Barrameda, | |
| H. Fundación Alcorcón_Cardiología Alcorcón, | |
| H.Sant Joan Despí_Dto. Cardiología Sant Joan Despí, Catalonia | |
| HCL-HOPITAL LYON SUD_Service d'Endocrinologie-Diabète-Nutrition Pierre-Bénite, | |
| Hadassah Ein Karam MC - Cardio Department Jerusalem, | |
| Haemek MC - Research Unit of Internal Medicine C Afula, | |
| Hallym University Sacred Heart Hospital_Cardiology Anyang-si, Gyeonggi-do | |
| Halton Healthcare Oakville, Ontario | |
| Hanyang university seoul hospital_Cardiology Seoul, | |
| Hawthorne Health Diamondhead, Mississippi | |
| Hawthorne Health NC Concord, North Carolina | |
| Hayama Heart Center_Cardiology Miura-gun, Kanagawa, | |
| Healthworld hospitals Durgapur, West Bengal | |
| Heart House - Sewell Sewell, New Jersey | |
| Heart House - Vineland Vineland, New Jersey | |
| Heart of Australia Chelmer, Queensland | |
| Helderberg Research Institute Cape Town, Western Cape | |
| Henry Ford Health System Detroit, Michigan | |
| Herlev Hospital - Afdeling for Hjertesygdomme, Forskning 1 Herlev, Capital Region | |
| Herz- und Diabeteszentrum NRW - Bad Oeynhausen Bad Oeynhausen, | |
| Herz-Kreislauf-Zentrum Klinikum Hersfeld-Rotenburg GmbH - Zentrum für Klinische Forschung Rotenburg A. D. Fulda, | |
| Herz-Lungen-Zentrum Weyhe-Leeste Weyhe, | |
| Higashi Takarazuka Satoh Hospital_Cardiology Hyōgo, | |
| Higashiosaka City Medical Center_Cardiovascular Medicine Higashiosaka-shi, Osaka, | |
| High Desert Heart and Vascular PLLC Meridian, Idaho | |
| Hillel Yaffe MC - Cardiology Department Hadera, | |
| Holbæk Sygehus - Forskningsenheden, Medicinsk Afdeling, afs. 44-4 Holbæk, Region Sjælland | |
| Honor Health Scottsdale, Arizona | |
| Hope Clin Res & Wellness Conyers, Georgia | |
| Hope Research Network Virginia Gardens, Florida | |
| Horizon Research Group of Opelousas, LLC Eunice, Louisiana | |
| Hosp. Comarcal de Antequera_Medicina Interna Antequera, | |
| Hosp. U Gran Canaria Dr. Negrín_Cardiologia Las Palmas de Gran Canaria, | |
| Hosp. Univ. de Jaén_Cardiología Jaén, | |
| Hosp. Virgen de las Montañas_Medicina Interna Villamartín, | |
| Hospital 12 de Octubre Madrid, | |
| Hospital Alemão Oswaldo Cruz São Paulo, | |
| Hospital Canselor Tuanku Muhriz UKM Cheras, Kuala Lumpur | |
| Hospital Clinico Universitario de Valencia Valencia, | |
| Hospital De La Santa Creu I Sant Pau Barcelona, | |
| Hospital Espanol De Mendoza Mendoza, | |
| Hospital General de Mexico (HGM) Cuauhtémoc, México, D.F. | |
| Hospital Germans Trias I Pujol Badalona, Barcelona [barcelona] | |
| Hospital Kuala Lumpur Kuala Lumpur, FED. Territory of Kuala Lumpur | |
| Hospital Miri Miri, Sarawak | |
| Hospital Pakar Sultanah Fatimah Muar town, Johor | |
| Hospital Ramón.y Cajal_Med. Interna Madrid, | |
| Hospital Serdang Kajang, Selangor | |
| Hospital Sultanah Aminah Johor Bahru, Johor | |
| Hospital Sultanah Bahiyah Alor Setar, Kedah, | |
| Hospital Taiping Taiping, Perak | |
| Hospital Tengku Ampuan Afzan Kuantan, Pahang | |
| Hospital Tuanku Fauziah Kangar, Perlis, | |
| Hospital Univ. La Luz_Cardiología Madrid, | |
| Hospital Univ. Virgen de la Arrixaca El Palmar, Murcia | |
| Hospital Univ. de Gerona Doctor Josep Trueta Girona, | |
| Hospital Universitario Austral - Instituto de Cardiologia Pilar, Buenos Aires | |
| Hospital Universitario Dr. José Eleuterio González_Monterrey Monterrey, Nuevo León | |
| Hospital Universitario La Paz Madrid, | |
| Hospital Universitario Lucus Augusti Lugo, | |
| Hospital Universitario Puerta de Hierro Majadahonda Majadahonda, | |
| Hospital Universitario Virgen de Valme Seville, | |
| Hospital Universitario Virgen de las Nieves Granada, | |
| Hospital Universitario Virgen del Rocio Seville, Andalusia | |
| Hospital Universitario y Politécnico La Fe Valencia, | |
| Hospital Universiti Sains Malaysia Kota Bharu, | |
| Hospital Vall d'Hebron Barcelona, | |
| Hospital Zambrano Hellion TecSalud Monterrey, Nuevo León | |
| Hospital de Basurto Bilbao, | |
| Hospital de Clínicas da Universidade Federal de Goiânia Goiânia/GO, | |
| Hospital de Clínicas de Porto Alegre Porto Alegre, | |
| Hospital de Manises Manises, | |
| Hvidovre Hospital Hjertemedicinsk Hvidovre, | |
| Hyogo Prefectural HarimaHimeji General Medical Center_Cardiology Himeji-shi, Hyogo, | |
| IAPES Pesquisa Clínica - Rede AME Saúde Recife, Pernambuco | |
| ICM - Instituto do Coração de Marília Marília, | |
| ICOT Istituto Marco Pasquali - UOC Cardiologia Latina, | |
| IMA Research Mount Airy, North Carolina | |
| INECO Neurociencias Oroño Rosario, | |
| IRCCS Humanitas - UOC Cardiologia Rozzano, Milano | |
| IRCCS Ospedale Policlinico San Martino - U.O. Clinica di Malattie dell'Apparato Cardiovascolare e UTIC Genoa, Liguria | |
| IRCCS Policlinico San Matteo - S.C. Cardiologia Pavia, Lombardy | |
| IRCCS San Raffaele - Dipartimento area Cardiorespiratoria Rome, Lazio | |
| IUCPQ - Universite Laval Québec, | |
| Iaso Thessalia General Clinic Private Obstetrics S.A. - Cardiology Clinic Larissa, | |
| Iatros International Bloemfontein, | |
| Ind. Spec. Prak. Lek. w dziedz. Kardiologii lek. med. K. Cymerman Gdynia, Pomeranian Voivodeship | |
| Indiana University Health Methodist Hospital Indianapolis, Indiana | |
| Infinite Clinical Research Miami, Florida | |
| Inha University Hospital_Cardiology Incheon, | |
| Innera s.r.o. Benešov, | |
| InnoMed Clinical Trial Centre Cape Town, Western Cape | |
| Inpatient Research Clinic LLC Miami Lakes, Florida | |
| Inpatient Research Clinic LLC Miami Lakes, Florida | |
| Institut klinicke a experimentalni mediciny Prague, | |
| Instituto Cardiovascular de León S.C. León, Guanajuato | |
| Instituto Dante Pazzanese de Cardiologia São Paulo, | |
| Instituto Especialidades de la Salud Rosario Rosario, Santa Fe Province | |
| Instituto Medico Quirurgico San Rafael A Coruña, | |
| Instituto de Investigaciones Clinicas San Nicolas San Nicolás, | |
| Instituto de Investigaciones Clínicas Córdoba Córdoba, | |
| Instituto de Investigaciones Clínicas Rosario Rosario, | |
| Instituto de Investigaciones de Patologías Respiratorias San Miguel de Tucumán, | |
| Instituto de Moléstias Cardiovasculares de Tatuí Ltda Tatuí, São Paulo | |
| Instituto de Pesquisa Clinica de Campinas Campinas, | |
| Instituto do Coração - HCFMUSP São Paulo, São Paulo | |
| Intercard Spolka z ograniczona odpowiedzialnoscia Krosno, | |
| Intercoastal Medical Group Sarasota, Florida | |
| Intermountain Heart & Vascular Denver, Colorado | |
| Intermountain Medical Center Murray, Utah | |
| Internal Medicine Clin Trials Monterrey, Nuevo León | |
| Interventional Cardiology Medical Group West Hills, California | |
| InvivoCure Van Nuys, California | |
| InvivoCure -2 Denver, Colorado | |
| Iwate Prefectural Central Hospital_Cardiology Morioka-shi, Iwate, | |
| JA Shizuoka Kohseiren Enshu Hospital_Internal Medicine Hamamatsu-shi, Shizuoka, | |
| JPJ Research Northridge, California | |
| JSS Hospital, Mysore Mysuru, Karnataka | |
| Jacksonville Ctr for Clin Res Jacksonville, Florida | |
| Jantar Sp. z o.o. Ostrów Wielkopolski, | |
| Japanese Red Cross Wakayama Medical Center_Department of Cardiology Wakayama-shi, Wakayama, | |
| Javara Inc. / Privia Medical Group Gulf Coast PLLC Conroe, Texas | |
| Jawaharlal Nehru Medical College and Hospital Aligarh, Utter Pradesh | |
| Jeroen Bosch Zkh 's-Hertogenbosch, | |
| Jersey City Medical Center Jersey City, New Jersey | |
| Jinan Central Hospital-Cardiovascular Jinan, Shandong | |
| Jmf Clínica Do Coração Ltda Aracaju, | |
| Joe C.Wen & Fam CTR for Adv Care Irvine, California | |
| John Muir Physicians Network Concord, California | |
| Jongaie Research Pretoria West, Gauteng | |
| K&R Research Llc Marion, Ohio | |
| K2 Medical Research Orlando, Florida | |
| KARDIA - Dr. Hashemi Berlin, | |
| KG Hospital and PG Medical Institute & Research Centre Coimbatore, Tamil Nadu | |
| KLES Dr. Prabhakar Kore Hospital & Medical Research Centre Belagavi, Karnataka | |
| Kagawa Prefectural Central Hospital_Cardiovascular Medicine Takamatsu-shi, Kagawa, | |
| Kaiser Permanente Northern California San Francisco, California | |
| Kaohsiung Medical University Chung-Ho Memorial Hospital_Dept of Internal medicine Kaohsiung City, | |
| Kardio Elbl s.r.o. Brno - Sever, | |
| Kardio Life - Tomasz Borkowski Włocławek, Kuyavian-Pomeranian Voivodeship | |
| Kardiologicka ambulance Brno s.r.o. Brno, | |
| Kardiologie - Ústí nad Labem s.r.o. Ústí nad Labem, | |
| Kardiologie MUDr. Libor Nechvátal s.r.o. Brno, | |
| Kardiologie a Angiologie Praha s.r.o. Prague, | |
| Kardiologie im Spreebogen Berlin, | |
| Kardiologische Gemeinschaftspraxis Papenburg Papenburg, | |
| Kardiologische Praxis Ludwigshafen Ludwigshafen am Rhein, | |
| Kardiopraxis Schirmer Kaiserslautern, | |
| Karnataka Medical College and Research Institute Hubbali, Karnataka | |
| Kasugai Municipal Hospital_Cardiovascular Medicine Kasugai-shi, Aichi, | |
| Kath. Hospitalvereinigung Thüringen gGmbH - KKH St. Johann Nepomuk - Innere Med. II Erfurt, | |
| Kath. Klinikum Bochum gGmbH - St. Josef-Hospital Kardiologie Bochum, | |
| Kawartha Cardiology Clinical Trials Peterborough, Ontario | |
| Kayseri Şehir Hastanesi-Kardiyoloji Kayseri, | |
| Keimyung University Dongsan Hospital_Cardiology Daegu, | |
| King George's Medical University (KGMU) Lucknow, Uttar Pradesh | |
| King's College Hospital - Cardiology London, | |
| Klinika Dr. Pírka s.r.o. Mladá Boleslav, | |
| Kliniken Südostbayern AG - Klinikum Traunstein Traunstein, | |
| Kocaeli Üniversitesi Hastanesi- Kardiyoloji Kocaeli, | |
| Konstantopouleio G.H. of Athens, "Agia Olga" Athens, | |
| Korea University Anam Hospital_Cardiology Seoul, | |
| Korea University Guro Hospital_Cardiology Seoul, | |
| Krishna Vishwa Vidyapeeth Karad, Maharashtra | |
| Kütahya Şehir Hastanesi-Kardiyoloji Kütahya, | |
| LES HOPITAUX DE CHARTRES_HOPITAL LOUIS PASTEUR_Service de Cardiologie Le Coudray, | |
| Laurelton Heart Specialist PC Rosedale, New York | |
| Life Care Hospital and Research Centre Bangalore, Karnataka | |
| Life Clinical Research Ipswich, Queensland | |
| Lincoln County Hospital Lincoln, | |
| Lindner Center,Christ Hospital Cincinnati, Ohio | |
| Lisie Hospital Kochi, | |
| Lister Hospital Stevenage, | |
| Louis Stokes Clvlnd VA Med Ctr Cleveland, Ohio | |
| Lps Institute of Cardiology, Gsvm Medical College Kanpur, Uttar Pradesh | |
| Lyell McEwin Hospital - Clinical Trials Unit Elizabeth Vale, South Australia | |
| MBAL Trakia EOOD Stara Zagora, | |
| MC Diamedical - 2013 OOD, Dimitrovgrad Dimitrovgrad, | |
| MC Diamedical - 2013 OOD, Sofia Sofia, | |
| MC Hera EOOD - Sofia Sofia, | |
| MC Nevromedics EOOD, Cardiology Veliko Tarnovo, | |
| MEDICUS SERVICES s.r.o. Brandýs nad Labem, | |
| MHAT - City Clinic - Sveti Georgi EOOD Montana, | |
| MHAT - Dobrich AD, Cardiology Dobrich, | |
| MHAT - Ivan Skenderov EOOD Gotse Delchev, | |
| MHAT Heart and Brain EAD - Burgas, Cardiology Burgas, | |
| MHAT Heart and Brain EAD - Pleven, Cardiology Pleven, | |
| MHAT Sveta Sofia EOOD Sofia, | |
| MIT Medicina, Investigación y tratamiento Santa Rosa, La Pampa, | |
| MVZ CCB Frankfurt Und Main-Taunus GbR Frankfurt, | |
| MVZ im Altstadt-Carree Fulda GmbH - Zentrum für klinische Studien Fulda, | |
| Maasstad Ziekenhuis - Cardiologie Rotterdam, | |
| Main Heart Clinic Houston, Texas | |
| MaineHealth Cardiology - Biddeford Biddeford, Maine | |
| Malla Reddy Narayana Multispeciality Hospital Hyderabad, Telangana | |
| Marienhaus Klinikum Mainz GmbH - Innere Medizin I Mainz, | |
| Marmara Üniversitesi Pendik EAH- Kardiyoloji Istanbul, | |
| Marshfield Clinic Marshfield, Wisconsin | |
| Maxima MC Veldhoven - Cardiologie Veldhoven, | |
| Med Trust Research, Inc. Courtice, Ontario | |
| Med. Uni. of SC Ashley River T Charleston, South Carolina | |
| Medanta - The Medicity Multi-Speciality Hospital, Gurugram Gurgaon, Haryana | |
| Medical Care and Research S. A de C.V Mérida, Yucatán | |
| Medical Center Cardiohelp EOOD, Cardiology Consulting room Sofia, | |
| Medical Center Medconsult Pleven OOD Pleven, | |
| Medical Center Medica Plus Ltd. Veliko Tarnovo, | |
| Medical Center Nov Rehabilitatsionen center EOOD Stara Zagora, | |
| Medical center ISUL - Tsaritsa Yoanna EOOD Sofia, | |
| Medical center Kalimat EOOD Sofia, | |
| Medical center Medconsult Burgas OOD Burgas, | |
| Medical centre Zdrave 1 OOD Kozloduy, | |
| Meditrial Clinical Research Centre Pietermaritzburg, KwaZulu-Natal | |
| Medizentrum Essen-Borbeck Essen, | |
| Medizinisches Versorgungszentrum Am Bahnhof Spandau GbR Berlin, | |
| Medon Clinical Research Sp. z o.o. Warsaw, | |
| Medrasa Clinical Research Wylie, Texas | |
| Mehmet Akif Ersoy Göğüs Kalp ve Damar Cerrahisi EAH Istanbul, | |
| Mercy Gilbert Medical Center Gilbert, Arizona | |
| Mercy Medical Center, GI Research Baltimore, Maryland | |
| Mersin Üniversitesi Hastanesi- Kardiyoloji Mersin, | |
| Metabolica Sp. z o.o. Tarnów, | |
| Methodist Medical Center of Illinois Peoria, Illinois | |
| Metropolitan General Hospital Healthcare Facilities Operation And Management Single Member S.A. - Cardiology Clinic Athens, | |
| Michal Tomaszewski Indywidualna Praktyka Lekarska Lublin, | |
| Midwest Cardiovascu Rsrch Foundation Elkhart, Indiana | |
| Mission Cardiovascular Research Institute Fremont, California | |
| Mita Clinic of Internal Medicine and Cardiology_Cardiology Sapporo-shi, Hokkaido, | |
| Mobile Heart USA Health Cardiology Clinic Mobile, Alabama | |
| Mohak Bariatrics and Robotics Indore, Madhya Pradesh | |
| Monument Health Clinical Rsrch Rapid City, South Dakota | |
| Mount Sinai Hosp at NYC New York, New York | |
| Musgrove Park Hospital - Cardiology Taunton, | |
| NIPPON MEDICAL SCHOOL HOSPITAL_Cardiovascular medicine Bunkyo-ku, Tokyo, | |
| NSC Research, Inc Johns Creek, Georgia | |
| NYU Langone Med Assoc Chelsea New York, New York | |
| NYU Langone Orthopedic Center New York, New York | |
| NZOZ "Twoje Zdrowie EL" Sp. z o.o. Elblag, | |
| NZOZ SALUSMED Jan Zbigniew Peruga PPHU SALUS Lodz, | |
| Nagasaki Harbor Medical Center_Cardiovascular medicine Nagasaki, | |
| Nanjing Jiangning Hospital-Cardiovascular Nanjing, Jiangsu | |
| Narodowy Instytut Kardiologii Stefana Kardynala Wyszynskiego Panstwowy Instytut Badawczy Warsaw, | |
| National Center for Global Health and Medicine_Cardiology Shinjuku-ku, Tokyo, | |
| National Heart Institute Beverly Hills, California | |
| National Heart Institute,India New Delhi, | |
| National Hospital Organization Chiba Medical Center_Cardiovascular Medicine Chiba-shi,Chiba, | |
| National Hospital Organization Kyoto Medical Center_Cardiology Kyoto-shi, Kyoto, | |
| National Hospital Organization Mito Medical Center_Cardiovascular medicine Ibaraki, | |
| Nature Coast Clinical Research Crystal River, Florida | |
| Nemocnice Jihlava, p.o. Jihlava, | |
| Niels-Stensen-Kliniken Marienhospital Osnabrück - Klinik für Innere Medizin, Kardiologie und Intensivmedizin Osnabrück, | |
| Nightingale Research Adelaide Adelaide, South Australia | |
| Nightingale Research Victoria Frankston, Victoria | |
| Ninewells Hospital Dundee, | |
| Nkpsims & Rc , Lata Mangeshkar Hospital , Hingna Nagpur, Maharashtra | |
| Norfolk and Norwich University Hospital - Clinical Research Facility Norwich, Norfolk | |
| North Texas Research Associates McKinney, Texas | |
| North Tyneside General Hospital North Shields, | |
| North York Diagn & Cardiac Ctr North York, Ontario | |
| NorthBay Clinical Research Santa Rosa, California | |
| Northeast Georgia Medical Ctr Gainesville, Georgia | |
| Northwick Park Hospital - Cardiac Research Dept Harrow, | |
| Nova Scotia Health Halifax, Nova Scotia | |
| OCIPSMCC - Dr. Aleksandar Nosikov Sofia, | |
| Oaxaca Site Management Organization (OSMO) Oaxaca City, Oaxaca | |
| Ocala Cardiovascular Research Ocala, Florida | |
| Ordu Üniversitesi Eğitim ve Araştırma Hastanesi- Kardiyoloji Altınordu/Ordu, | |
| Oregon Health & Science University Portland, Oregon | |
| Ormond Beach Clinical Research Ormond Beach, Florida | |
| Osaka General Medical Center_Cardiology Osaka, | |
| Osaka Metropolitan University Hospital_Cardiovascular Medicine Osaka-Shi, Osaka, | |
| Osmania General Hospital Hyderabad, Telangana | |
| Ospedale Bellaria Carlo Alberto Pizzardi - UO Cardiologia e Unità coronarica Bologna, Emilia-Romagna | |
| Ospedale Ca' Foncello - U.O.C. Medicina Generale 1 Treviso, Veneto | |
| Ospedale Cremona - U.O. Cardiologia Cremona, Lombardy | |
| Ospedale Misericordia Grosseto - UOC Cardiologia Grosseto, Tuscany | |
| Ospedale S. Maria della Misericordia - Clinica Medica Udine Udine, Friuli Venezia Giulia | |
| Ospedale SS. Annunziata di Chieti - U.O. Clinica medica Medicina generale 1 Chieti, Abruzzo | |
| Ospedale San Raffaele S.r.l. - Unità Clinica Anestesia, Rianimazione e Terapia Intensiva Cardio-Toraco-Vascolare Milan, Lombardy | |
| Ospedale Santissima Annunziata - Dipartimento Cardio Toraco Vascolare Cosenza, Calabria | |
| Ospedale di Bentivoglio - UOC Cardiologia Bentivoglio, Emilia-Romagna | |
| Osrodek Badan Klinicznych LabMed Sp. z o.o. Szczecin, West Pomeranian Voivodeship | |
| Ota Memorial Hospital_Cardiology Ota-shi, Gunma, | |
| PHC Accelacare Statesville, North Carolina | |
| PUCCAMP - Hospital e Maternidade Celso Pierro Campinas, São Paulo | |
| Pacific Clinical Studies Los Alamitos, California | |
| Palm Research Center Inc-Vegas Las Vegas, Nevada | |
| Panamerican Clinical Research Mexico S. A de C.V Querétaro City, Querétaro | |
| Peachtree Cardiology Peachtree, Georgia | |
| Peak Clinical Trials Apex, North Carolina | |
| Penn Med. Lancaster Gen Hospital Lancaster, Pennsylvania | |
| Penn State Hlth Holy Spirit Med Ctr Camp Hill, Pennsylvania | |
| PharmaTex Research, LLC Amarillo, Texas | |
| Physicians East Endocrinology Greenville, North Carolina | |
| Piedmont Research Partners, LLC Fort Mill, South Carolina | |
| Pinderfields Hospital - Clinical Research & Innovation Wakefield, | |
| Pol. Uni. Campus Biomedico - UOC Cardiologia Rome, Lazio | |
| Policlinico San Donato di Milano S.p.A - UO Cardiologia Universitaria Perioperatoria e Riabilitativa San Donato Milanese, Lombardy | |
| Policum Berlin Studien GmbH - Friedenau Berlin, | |
| Pratia Czech, s.r.o. Prague, | |
| Praxis Dr. med. Jens Taggeselle Markkleeberg, | |
| Praxis Joachim Heisters Kamp-Lintfort, | |
| Praxis für Innere Medizin, Kardiologie, Pneumologie - Köln Cologne, | |
| Princess of Wales Hospital Bridgend, | |
| Pro Familia Altera Sp. z o.o. Katowice, Silesian Voivodeship | |
| Proactive El Paso LLC El Paso, Texas | |
| Providence Health Partners Ctr Dayton, Ohio | |
| Prywatna Praktyka Lekarska Anna Chudoba Żyrardów, Masovian Voivodeship | |
| Pusan National University Yangsan Hospital_Cardiology Yangsan, Gyeongsangnam-do | |
| Raigmore Hospital Inverness, Highland | |
| Rambam MC - Heart Failure Unit Haifa, | |
| Regionshospital Nordjylland, Hjørring - Afdelingen for hjerte- og hormonsygdomme Hjørring, | |
| Renal Disease Research Institute Dallas, Texas | |
| Research Integrity Global, LLC Owensboro, Kentucky | |
| Rhythm Heart Institute Vadodara, Gujarat | |
| Rigshospitalet - Kardiologisk Forskningsenhed København Ø, | |
| Robert-Bosch-Krankenhaus Stuttgart - Behandlungsexzellenz Bosch Health Campus Stuttgart, | |
| Rode Kruis Zkh Beverwijk - Cardiologie Beverwijk, | |
| Royal Cornwall Hospital (Treliske) Truro, Cornwall | |
| Royal Hobart Hospital - Cardiology Department Hobart, Tasmania | |
| Royal Victoria Infirmary Newcastle, England | |
| Ruppiner Kliniken - Universitätsklinikum Ruppin-Brandenburg Neuruppin, | |
| SAKAKIBARA HEART INSTITUTE_Cardiology Fuchu-shi,Tokyo, | |
| SEC Clinical Research Pensacola, Florida | |
| SHATC - Cardiolife OOD - Varna Varna, | |
| SIYODE S.A. de C.V. Unimeden Ciudad Madero, Tamaulipas | |
| SLK-Klinken Heilbronn - Klinikum am Plattenwald Bad Friedrichshall Bad Friedrichshall, | |
| SMC Heart Institute and IVF Research Centre Raipur, Chhattisgarh | |
| SPIMED, s.r.o. Česká Třebová, | |
| STAT Research Ohio Vandalia, Ohio | |
| Sakarya Eğitim ve Araştırma Hastanesi- Dahiliye Adapazarı/Sakarya, | |
| Samodzielny Publiczny Specjalistyczny Szpital Zachodni Im.Sw.Jana Pawla II Grodzisk Mazowiecki, Masovian Voivodeship | |
| Samodzielny Publiczny Zaklad Opieki Zdrowotnej Ministerstwa Spraw Wewnetrznych i Administracji w Rzeszowie Rzeszów, | |
| Samsun Şehir Hastanesi-Kardiyoloji Canik/Samsun, | |
| Samsung Medical Center_Cardiology Seoul, | |
| San Diego Veterans Affairs San Diego, California | |
| San Francisco V.A. Medical Center San Francisco, California | |
| Sana Kliniken Oberfranken Coburg GmbH - II. Med. Klinik, Kardiologie Coburg, Thuringia | |
| Sanatorio Esperanza Esperanza, Santa Fe, | |
| Sanjay Gandhi Postgraduate Institute of Medical Sciences Lucknow, Uttar Pradesh | |
| Sarawak General Hospital Buzia?, Sarawak | |
| Schwarzwald-Baar Klinikum Villingen-Schwenningen GmbH Villingen-Schwenningen, | |
| Scientia Investigación Clínica S. C. Col. Zona Comercial Plaza Del Sol, Chihuahua | |
| Scripps Hospital Chula Vista, California | |
| Scripps Memorial Hospital La Jolla La Jolla, California | |
| Sekino Hospital_Internal Medicine Toshima-ku,Tokyo, | |
| Selma Medical Associates Winchester, Virginia | |
| Sengupta Hospital and Research Institute Nagpur, Maharashtra | |
| Sentara Health Research Center Norfolk, Virginia | |
| Seoul National University Bundang Hospital_Cardiology Seongnam-si, Gyeonggi-do | |
| Seoul National University Hospital_Cardiology Seoul, | |
| Serce Sp. z o.o. Leszno, Greater Poland Voivodeship | |
| Seth GS Medical College & KEM Hospital Mumbai, Maharashtra | |
| Severance Hospital, Yonsei University Health System_Cardiology Seoul, | |
| Shaanxi Provincial People's Hospital-Cardiology Xi'an, Shaanxi | |
| Shamir MC - Cardiology Department Beer Yaakov, | |
| Sherman Clinical Research Sherman, Texas | |
| Shinshu University Hospital__Department of Cardiology Matsumoto-shi, Nagano, | |
| Shri Mahant Indiresh Hospital Dehradun, | |
| Siping City Central People's Hospital-Cardiology Siping, Jilin | |
| Sir Ganga Ram Hospital New Delhi, | |
| Sismanogleio General Hospital - Amalia Fleming Hospital, Cardiology Department Athens, | |
| Slaskie Centrum Chorob Serca w Zabrzu Zabrze, Silesian Voivodeship | |
| Soroka MC - Department of Cardiology Beersheba, | |
| South Texas Clinical Research Corpus Christi, Texas | |
| Southmead Hospital - Cardiology Research Bristol, | |
| Southwest Family Medicine_Dallas Dallas, Texas | |
| Spaarne Gasthuis Haarlem, | |
| Specjalistyczny Szpital Im. E. Szczeklika W Tarnowie Tarnów, | |
| Spedali Civili Brescia - U.O. Medicina Generale 2 Brescia, Lombardy | |
| Sri Ramachandra Medical Centre Chennai, Tamil Nadu | |
| St Bartholomew's Hospital London, London, CITY of | |
| St George's Hospital - Cardiology Tooting, London | |
| St Joseph's Hospital Foundation Tampa, Florida | |
| St Pauls Hospital Vancouver, British Columbia | |
| St. Antonius Zkh Nieuwegein - Cardiologie Nieuwegein, | |
| St. Boniface Hospital Winnipeg, Manitoba | |
| St. Joseph's Heath Centre Toronto, Ontario | |
| St. Joseph's Medical Center Stockton, California | |
| St. Luke's Idaho Cardiology Associates Meridian, Idaho | |
| St. Richard's Hospital_Cardiology Chichester, West Sussex | |
| Sun City Clinical Research Glendale, Arizona | |
| Suncoast Clinical Research, Inc. Palm Harbor, Florida | |
| Sunderland Royal Hospital Sunderland, | |
| Svendborg Sygehus - Kardiologisk Svendborg, Region South | |
| Swedish Medical Center_Seattle Seattle, Washington | |
| Sydney Cardiometabolic Centre Liverpool, New South Wales | |
| Sygehus Sønderjylland, Aabenraa - Afdeling for Hjertesygdomme Aabenraa, | |
| Synapta Clinical Research Durban, KwaZulu-Natal | |
| Synergy Biomed Research Institute East London, Eastern Cape | |
| Synvia Laboratorios E Toxicologia Ltda Campinas, São Paulo | |
| Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie Sp. z o.o. Krakow, | |
| TPMG Clinical Research Newport News, Virginia | |
| Taipei Mackay Memorial Hospital Taipei, | |
| Taipei Medical University Hospital Taipei, | |
| Tampa Cardiovascular Interventions and Research Tampa, Florida | |
| Texama Medical Center Denison, Texas | |
| Texas Health Heart and Vascular Specialists Dallas, Texas | |
| The Affiliated Hospital of Jining Medical University-Cardiology Jining, Shandong | |
| The Affiliated Hospital of Xuzhou Medical University-Cardiology Xuzhou, Jiangsu | |
| The Catholic University of Korea, Seoul ST. Mary's Hospital_Cardiology Seoul, | |
| The Catholic University of Korea. Uijeongbu St. Mary's Hospital_Cardiology Uijeongbu-si, Gyeonggi-do | |
| The First Affiliated Hospital of Harbin Medical University-Cardiovascular Harbin, Heilongjiang | |
| The First Affiliated Hospital of Jinan University-Cardiovascular Guangzhou, Guangdong | |
| The First Affiliated Hospital of Soochow University-Cardiology Suzhou, Jiangsu | |
| The First Hospital of Hebei Medical University-Cardiovascular Shijiazhuang, Hebei | |
| The First People's Hospital of Changzhou-Cardiology Changzhou, Jiangsu | |
| The GW Medical Faculty Associates Washington D.C., District of Columbia | |
| The Heart House Haddon Heights Haddon Heights, New Jersey | |
| The Jackson Clinic, PA Jackson, Tennessee | |
| The James Cook University Hospital - Cardiology Middlesbrough, | |
| The Medicity Super Speciality Hospital, Udham Singh Nagar, Uttarakhand | |
| The People's Hospital of Liaoning Province-Cardiology Shenyang, Liaoning | |
| The Prince Charles Hospital - Cardiology Clinical Research Centre Chermside, Queensland | |
| The Queen's Medical Center Honolulu, Hawaii | |
| The Research Group of Lexington LLC Lexington, Kentucky | |
| The Royal Oldham Hospital Oldham, | |
| The Third People's Hospital of Hubei Province (Qiaokou Campus)-Cardiology Wuhan, Wuhan | |
| The Valley Hospital Paramus Paramus, New Jersey | |
| Thomas Jefferson University Philadelphia, Pennsylvania | |
| Thoracic General Hospital Of Athens I Sotiria - Cardiology Department Athens, | |
| Tianjin People's Hospital-Cardiology Tianjin, Tianjin Municipality | |
| Tickerdoc Research (Pty) LTD Johannesburg, Gauteng | |
| Tiervlei Trial Centre Cape Town, Western Cape | |
| Tokyo-Eki Center-building Clinic_Internal Medicine Tokyo, | |
| Tomakomai City Hospital_Cardiology Tomakomai-Shi, Hokkaido, | |
| Torbay Hospital Torquay, | |
| Torre De Plaza Las Americas San Juan, | |
| Total Research Group LLC Miami, Florida | |
| Tread Research (Pty)Ltd Cape Town, Western Cape | |
| Trinity Health Michigan Heart Ypsilanti, Michigan | |
| Tsuchiura Kyodo General Hospital_Internal Medicine Ibaraki, | |
| Twoja Przychodnia-Szczecinskie Centrum Medyczne Sp. z o. o. Szczecin, | |
| U.G.H of Athens "Attikon" Chaidari, Athens, | |
| UCSD NAFLD Research Center La Jolla, California | |
| UMC Groningen - Cardiologie Groningen, | |
| UMC of Southern Nevada Las Vegas, Nevada | |
| UMHAT - Dr. Georgi Stranski EAD Pleven, | |
| UMHAT - EUROHOSPITAL PLOVDIV OOD, Department of Internal Diseases Plovdiv, | |
| UMHAT Aleksandrovska EAD, Clinic of Cardiology Sofia, | |
| UMHAT Sofiamed EAD Sofia, | |
| UMHAT Sveta Marina EAD, Second Clinic of Cardiology Varna, | |
| UMHAT Sveti Georgi EAD, Plovdiv, Clinic of Cardiology Plovdiv, | |
| UMHATEM N.I. Pirogov EAD, Cardiology department Sofia, | |
| UTD SW Medical Center-Dallas Dallas, Texas | |
| Ulster Hospital Belfast, | |
| UniCardia & UniMedica & UniEstetica Krakow, | |
| Uniklinik Aachen - Med. Klinik I Aachen, | |
| Uniklinik Schleswig-Holstein - Med. Klinik III Kardiologie und Internist. Intensivmedizin Kiel, | |
| Uniklinik TU Dresden - Herzzentrum Dresden GmbH Dresden, | |
| Univ Gen Hospital Larisa, Cardiology Medicine Clinic Larissa, | |
| Univ of Alabama Birmingham Birmingham, Alabama | |
| Univ of Colorado at Denver Aurora, Colorado | |
| Univ of Mississippi Med Center Jackson, Mississippi | |
| Univer Of Illinois at Chicago Chicago, Illinois | |
| Universidade Municipal de São Caetano do Sul (USCS) São Caetano Do Sul / SP, São Paulo | |
| Universitatsklinikum Würzburg - Zentrum für Herzinsuffizienz Würzburg, | |
| University Hospital San Antonio, Texas | |
| University Hospital Coventry - Cardiology Research PRI Suite Coventry, | |
| University Hospital Monklands - Cardiology Research Airdrie, Lanarkshire | |
| University Malaya Medical Centre Kuala Lumpur, FED. Territory of Kuala Lumpur | |
| University Technology MARA (UiTM) - Sg Buloh Sungai Buloh, Selangor | |
| University of Calgary Calgary, Alberta | |
| University of Iowa Iowa City, Iowa | |
| University of Michigan Ann Arbor, Michigan | |
| University of Rochester Rochester, New York | |
| University of Virginia Hospital Charlottesville, Virginia | |
| Universitätsklinikum Frankfurt aM - Kardiologie Frankfurt am Main, | |
| Universitätsklinikum Freiburg - Medical Center Freiburg im Breisgau, | |
| Universitätsklinikum Münster - Klinik für Kardiologie I Münster, | |
| Uniwersytecki Szpital Kliniczny Nr 2 Uniwersytetu Medycznego w Lodzi Lodz, Łódź Voivodeship | |
| Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wroclawiu Wroclaw, | |
| Uniwersytecki Szpital Kliniczny nr 4 w Lublinie Lublin, | |
| Uniwersytecki Szpital Kliniczny w Bialymstoku Bialystok, | |
| Uniwersyteckie Centrum Medycyny Morskiej i Tropikalnej Gdynia, | |
| UofL Health Care Outpatient Louisville, Kentucky | |
| Uwajima City Hospital_Cardiology Uwajima-shi, Ehime | |
| VA Eastern Colorado Health Care System Aurora, Colorado | |
| VAGrtrLosAngelesHlthcareSystem Los Angeles, California | |
| VMMC & Safdarjung Hospital New Dehli, New Delhi | |
| Valiance Clinical Research Huntington Park, California | |
| Valiance Clinical Research Huntington Park, California | |
| Valley Clinical Trials Covina, California | |
| Valley Clinical Trials Covina, California | |
| Van Weel-Bethesda Zkh - Cardiologie Dirksland, | |
| Velocity Clinical Research Lincoln Lincoln, Nebraska | |
| Velocity Nova Sp. z o.o. Staszów, Świętokrzyskie Voivodeship | |
| Velocity Nova Sp. z o.o. Staszów, Świętokrzyskie Voivodeship | |
| Viborg Sygehus Viborg, | |
| Victoria Hospital Kirkcaldy, | |
| Victorium Clinical Research Houston, Texas | |
| VieCuri - Cardiologie Venlo, | |
| Vijan Hospital & Research Centre Nashik, Maharashtra | |
| Virginia Commonwealth University Richmond, Virginia | |
| WMF's Villoo Poonawalla Memorial Hospital Pune, | |
| WVU Medicine Morgantown, West Virginia | |
| WakeMed_Cardiology Raleigh, North Carolina | |
| Washington University St Louis, Missouri | |
| West Houston Area Clinical Trial Consultants Wichita, Kansas | |
| West Middlesex University Hospital Isleworth, Middlesex | |
| Westchester Medical Center Valhalla, New York | |
| Westside Medical Associates Los Angeles Beverly Hills, California | |
| Winchester Dist Memorial Hosp Winchester, Ontario | |
| Wits Bara Clinical Trial Site Johannesburg, Gauteng | |
| Wits Clinical Research Johannesburg, Gauteng | |
| Wojewodzki Szpital Im. Sw.Ojca Pio W Przemyslu Przemyśl, | |
| Wojewodzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopernika Lodz, Łódź Voivodeship | |
| Women's College Hospital Toronto, | |
| Wonju Severance Christian Hospital_Cardiology Wŏnju, Gangwon-do | |
| Worcestershire Royal Hospital_Cardiology Worcester, | |
| Yamanashi Prefectural Central Hospital_Cardiology Kofu-shi, Yamanashi, | |
| Yokohama City University Hospital_Cardiovascular Medicine Yokohama-shi，Kanagawa, | |
| Yokohama City University Medical Center_Cardiovascular Center Kanagawa, | |
| Zentrum für klinische Studien Südbrandenburg GmbH Elsterwerda, | |
| Zhongshan Hospital, Fudan University-Cardiology Shanghai, Shanghai Municipality | |
| Ziv MC - Cardiology Department Safed, | |
| Zuyderland ziekenhuis - Cardiologie Heerlen, | |
| cardiologicum Hamburg - Studienzentrum Hamburg, | |
| Çanakkale Onsekiz Mart Üniversitesi Sağlık Araştırma ve Uygulama Hastanesi- Kardiyoloji Çanakkale/Türkiye, | |
| İnönü Üniversitesi Turgut Özal Tıp Merkezi - Kardiyoloji Malatya, | |
| İstanbul Üniversitesi-Cerrahpaşa Kardiyoloji Enstitüsü Istanbul, | |
| İzmir Atatürk Eğitim Ve Araştırma Hastanesi- Kardiyoloji Izmir, | |
| İzmir Şehir Hastanesi- Kardiyoloji Bayraklı/İzmir, |
Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials
Jonathan Soslow, MD, MSCI - DMDMachineLearning@vumc.org
NCT07674758
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
* Clinical phenotype of Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), or muscular dystrophy carrier (MDC) confirmed with muscle biopsy or genotype
Exclusion Criteria:
* Additional genetic or congenital abnormality that may affect cardiovascular function or progression
* Current investigational therapy that may affect cardiovascular function (would preclude ongoing data collection but prior data would still be used) Duchenne Muscular Dystrophy (DMD), Cardiomyopathy, Becker Muscular Dystrophy, Carrier of Duchenne Muscular Dystrophy
Duchenne Muscular Dystrophy, cardiomyopathy, machine learning, cardiac MRI, Biomarker, Outcome measures
I'm interested
Share via email
Show 9 locations
Study Locations
Hide all locations
| Location | Contacts |
|---|---|
| Children's Hospital of Richmond at VCU Richmond, Virginia | Study Coordinator - (DMDmachinelearning@vumc.org) |
| Children's National Washington D.C., District of Columbia | Study Coordinator - (DMDmachinelearning@vumc.org) |
| Duke Children's Hospital Durham, North Carolina | Study Coordinator - (DMDmachinelearning@vumc.org) |
| Lurie Children's Chicago, Illinois | |
| Nationwide Children's Columbus, Ohio | Study Coordinator - (DMDmachinglearning@vumc.org) |
| Riley Children's Hospital Indianapolis, Indiana | Study Coordinator - (DMDMachineLearning@vumc.org) |
| Seattle Children's Seattle, Washington | Study Coordinator - (DMDmachinelearning@vumc.org) |
| UC Davis Sacramento, California | Study Coordinator - (DMDmachinelearning@vumc.org) |
| Vanderbilt University Medical Center Nashville, Tennessee | Study Coordinator - (DMDMachineLearning@vumc.org) |
Endocardial Mapping With the CoreMap EP Mapping System (INvENI)
Jim Foster, SysEng - jfoster@coremapmedical.com
NCT06529978
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
• Subject has persistent or long-standing persistent AF, at the discretion of the investigator (Phase 1 \& 2)
• Subject has PerAF with no history of prior AF ablation therapy (Phase 3)
• Subject is 18 to 80 years of age
• Subject has presence of AF-related symptoms and is scheduled for clinically indicated standard of care AF ablation to manage PerAF (Phase 2 or 3) or long-standing PerAF (Phase 2)
• Subject is able to provide written informed consent
• Subject is able and willing to complete all study procedures
Exclusion Criteria:
• Any of the following within three months of enrollment:
• Myocardial infarction (MI)
• Any surgical or percutaneous cardiac procedure including coronary intervention and cardiac ablation
• Confirmed thrombus on imaging
• Any of the following within six months of enrollment:
• Cardiac surgery including coronary artery bypass grafting, ventriculotomy, atriotomy
• Thromboembolic event (stroke)
• Any of the following cardiac conditions:
• New York Heart Association (NYHA) IV
• Left ventricular ejection fraction (LVEF) \< 30%
• Left atrial diameter \>55mm (anterioposterior) (Phase 3)
• Carotid stenting or endarterectomy
• Atrial or ventricular septal closure or left atrial appendage closure
• Implanted permanent pacemaker, biventricular pacemaker, or any type of implantable cardiac defibrillator; loop recorders are permitted.
• Presence of intramural thrombus, tumor (including atrial myxoma), or other abnormality that precludes vascular access, catheter introduction, or manipulation
• Unstable angina
• Prior mitral or tricuspid valve surgery, repair, prosthetic or mechanical valve
• Moderate to severe mitral valve stenosis or other severe valvular disease
• Any blood clotting or bleeding abnormalities
• Contraindication to systemic anticoagulation
• AF secondary to electrolyte imbalance, acute alcohol intoxication, or reversible or non-cardiac cause
• Body mass index (BMI) \> 40 kg/m2
• Severe pulmonary disease, pulmonary hypertension, or any chronic respiratory condition
• Renal failure requiring dialysis or transplant
• Acute illness, active systemic infection, or sepsis
• Active drug or alcohol dependency
• Hypertrophic cardiomyopathy or cardiac amyloidosis
• Cor pulmonale
• Any contra-indication that may extend procedure time, at the discretion of the operator
• Any woman known to be pregnant or breastfeeding, or any woman of childbearing potential who is not on a reliable form of birth regulation method or abstinence
• Subject considered part of vulnerable population
• Life expectancy less than one year
• Employee of the study site or Sponsor
• Subjects who are currently enrolled in another study that would directly interfere with this study
DEVICE: CoreMap EP Mapping System Mapping, DEVICE: CoreMap EP Mapping System Map-Guided Ablation
Persistent Atrial Fibrillation
I'm interested
Share via email
Show 4 locations
Study Locations
Hide all locations
| Location | Contacts |
|---|---|
| NCH Downtown Baker Hospital Naples, Florida | |
| Na Homolce Hospital Praha Klanovice, | |
| University of Vermont Medical Center Burlington, Vermont | |
| Virginia Commonwealth University (VCU) Richmond, Virginia |
The Value of a Simple Tool for the Early Detection of Decompensated Heart Failure in People Over 55 on Réunion Island: A Preliminary Study in Hospitals (DEPIST'IC-RUN) (DEPIST'IC-RUN)
Jérôme CORRE, Dr - jerome.corre@chu-reunion.fr
NCT07673562
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
Patients:
* Aged 55 and older
* Admitted on an unscheduled basis to the cardiology department at the CHU (North and South campuses) and the CHOR for any reason (in general wards or intensive care)
* Residents of Réunion
* Able to read and write French
* Enrolled in a social security program
* Willing to participate in the study
Exclusion Criteria:
Patients:
* Who cannot communicate in French
* For whom it is impossible to administer the questionnaire
* For whom the ETT and/or cardiology consultation are impossible
* Who are under guardianship, conservatorship, or judicial protection DIAGNOSTIC_TEST: Early Detection Questionnaire
Heart Failure
Decompensated heart failure, early detection, questionnaire
I'm interested
Share via email
Show 3 locations
Study Locations
Hide all locations
| Location | Contacts |
|---|---|
| CHOR Saint-Paul, Reunion | Fanny LE MEE, Dr - (fa.lemee@chor.re) |
| CHU Réunion - NORD Saint-Denis, Reunion | Jérome CORRE, Dr - (jerome.corre@chu-reunion.fr) |
| CHU Réunion- SUD Saint-Pierre, Reunion | Pierre ROUMEGOU, Dr - (pierre.roumegou@chu-reunion.fr) |
Autonomic and Renal Contributions to Hypertension With ADT (ARCH)
Matthew Babcock, PhD - babcockmc@vcu.edu
NCT07848828
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
* age 40+ years;
* resting blood pressure \<140/90 mmHg;
* fasted blood glucose \<126 mg/dL;
* testosterone ≥400 ng/dL;
* sedentary to recreationally active;
* nonsmokers;
* healthy as determined by medical history, physical exam, blood and urine chemistries and resting and exercise ECG during a physician supervised graded exercise treadmill test OR recent diagnosis of non-metastatic prostate cancer with plans to undergo androgen deprivation therapy;
* PSA \<4.00 ng/dL if in the non-cancer group;
* Gleason Score ≤7 if in the prostate cancer group;
* no use of medications that might influence cardiovascular function (e.g., antihypertensives, lipid-lowering medications);
* willing and able to be on GnRHagonist and AR inhibitor;
* not taking antioxidant vitamins, corticosteroids, or anti-inflammatory medications, or willing to stop use for four weeks prior to the start of the study;
* not using exogenous sex hormones for at least one year
Exclusion Criteria:
* -acute liver disease;
* chronic kidney disease, serum creatinine \>1.3 mg/dL, macroalbuminuria \>300 mg/g of proteinuria
* pre-existing or active cardiac, renal or hepatic disease, epilepsy or other seizure disorder;
* diabetes, active or chronic infection, disease that affects the nervous system;
* Gleason Score ≥8;
* thyroid dysfunction, defined as ultrasensitive TSH \<0.5 or \>5.0 mU/L, volunteers with abnormal TSH values will be re-considered for participation after follow-up evaluation by the PCP with initiation or adjustment of thyroid hormone replacement;
* tobacco use within the previous 12 months DRUG: Gonadotropin Releasing Hormone Agonists (GNRH), DRUG: Androgen receptor (AR) inhibitor, DRUG: Placebo
Androgen Deprivation Therapy, Prostate Cancer, Hypertension, Autonomic Dysfunction, Renal Disease
I'm interested
Share via email
Show 1 location
Study Locations
Hide all locations
| Location | Contacts |
|---|---|
| Virginia Commonwealth University Richmond, Virginia | Matthew Babcock, PhD - (babcockmc@vcu.edu) |